Staff Publications: June 2018

1. Bartel MJ, Srivastava A, Pohl H. Response. Gastrointest Endosc. 2018;88(1):201. PMID: 29935617.
https://www.ncbi.nlm.nih.gov/pubmed/29935617
.
2. Battistuzzi FU, Tao Q, Jones L, Tamura K, Kumar S. Reltime Relaxes the Strict Molecular Clock Throughout the Phylogeny. Genome Biol Evol. 2018;10(6):1631-1636. PMID: 29878203. PMC6022624.
https://www.ncbi.nlm.nih.gov/pubmed/29878203.

3. Beatty A, Fink LS, Singh T, et al. Metabolite Profiling Reveals the Glutathione Biosynthetic Pathway as a Therapeutic Target in Triple-Negative Breast Cancer. Mol Cancer Ther. 2018;17(1):264-275. PMID: 29021292. PMC5892195. https://www.ncbi.nlm.nih.gov/pubmed/29021292.

4. Beaufay C, Ledoux A, Jansen O, et al. In Vivo Antimalarial and Antitrypanosomal Activity of Strychnogucine B, a Bisindole Alkaloid from Strychnos Icaja. Planta Med. 2018. PMID: 29929205.
https://www.ncbi.nlm.nih.gov/pubmed/29929205.

5. Bichakjian CK, Olencki T, Aasi SZ, et al. Merkel Cell Carcinoma, Version 1.2018, Nccn Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2018;16(6):742-774. PMID: 29891526.
https://www.ncbi.nlm.nih.gov/pubmed/29891526.

6. Cagney DN, Martin AM, Catalano PJ, et al. Impact of Pemetrexed on Intracranial Disease Control and Radiation Necrosis in Patients with Brain Metastases from Non-Small Cell Lung Cancer Receiving Stereotactic Radiation. Radiother Oncol. 2018;126(3):511-518. PMID: 29398153.
https://www.ncbi.nlm.nih.gov/pubmed/29398153.

7. Cahn DB, Handorf EA, Smaldone MC. Bladder Extirpation Vs Preservation: The Treatment Debate. JAMA Surg. 2018. PMID: 29955758.
https://www.ncbi.nlm.nih.gov/pubmed/29955758.

8. Carqueijeiro IT, Brown S, Chung K, et al. Two Tabersonine 6,7-Epoxidases Start Synthesis of Lochnericine-Type Alkaloids in Catharanthus Roseus. Plant Physiol. 2018. PMID: 29934299.
https://www.ncbi.nlm.nih.gov/pubmed/29934299.

9. Chhatre S, Jefferson A, Cook R, et al. Patient-Centered Recruitment and Retention for a Randomized Controlled Study. Trials. 2018;19(1):205. PMID: 29587805. PMC5870194. https://www.ncbi.nlm.nih.gov/pubmed/29587805.

10. Doss M. Letter by Doss Regarding Article, “Radiation-Induced DNA Damage in Operators Performing Endovascular Aortic Repair”. Circulation. 2018;137(24):2678-2679. PMID: 29891633.
https://www.ncbi.nlm.nih.gov/pubmed/29891633.

11. Drilon A, Laetsch TW, Kummar S, et al. Efficacy of Larotrectinib in Trk Fusion-Positive Cancers in Adults and Children. N Engl J Med. 2018;378(8):731-739. PMID: 29466156. PMC5857389.
https://www.ncbi.nlm.nih.gov/pubmed/29466156.

12. Engel N. Sex Differences in Early Embryogenesis: Inter-Chromosomal Regulation Sets the Stage for Sex-Biased Gene Networks: The Dialogue between the Sex Chromosomes and Autosomes Imposes Sexual Identity Soon after Fertilization. Bioessays. 2018. PMID: 29943439.
https://www.ncbi.nlm.nih.gov/pubmed/29943439.

13. Ferris RL, Nikiforov Y, Terris D, et al. Ahns Series: Do You Know Your Guidelines? Ahns Endocrine Section Consensus Statement: State-of-the-Art Thyroid Surgical Recommendations in the Era of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features. Head Neck. 2018. PMID: 29947030.
https://www.ncbi.nlm.nih.gov/pubmed/29947030.

14. Garriga J, Laumet G, Chen SR, et al. Nerve Injury-Induced Chronic Pain Is Associated with Persistent DNA Methylation Reprogramming in Dorsal Root Ganglion. J Neurosci. 2018;38(27):6090-6101. PMID: 29875269. PMC6031579.
https://www.ncbi.nlm.nih.gov/pubmed/29875269.

15. Goel N, Manstein SM, Ward WH, et al. Does the Surgical Apgar Score Predict Serious Complications after Elective Major Cancer Surgery? Journal of Surgical Research. 2018;231:242-247. PMID: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85048879022&doi=10.1016%2fj.jss.2018.05.037&partnerID=40&md5=045488d6a0213fe036c9e039a4d2a332.
16. Golemis EA, Scheet P, Beck TN, et al. Molecular Mechanisms of the Preventable Causes of Cancer in the United States. Genes Dev. 2018;32(13-14):868-902. PMID: 29945886. https://www.ncbi.nlm.nih.gov/pubmed/29945886.

17. Good CR, Panjarian S, Kelly AD, et al. Tet1-Mediated Hypomethylation Activates Oncogenic Signaling in Triple-Negative Breast Cancer. Cancer Res. 2018. PMID: 29891505. https://www.ncbi.nlm.nih.gov/pubmed/29891505.

18. Haifler M, Ristau BT, Higgins AM, et al. External Validation of Contact Surface Area as a Predictor of Postoperative Renal Function in Patients Undergoing Partial Nephrectomy. J Urol. 2017. PMID: 28941921.
https://www.ncbi.nlm.nih.gov/pubmed/28941921.

19. Hayakawa K, Formica AM, Nakao Y, et al. Early Generated B-1-Derived B Cells Have the Capacity to Progress to Become Mantle Cell Lymphoma-Like Neoplasia in Aged Mice. J Immunol. 2018;201(2):804-813. PMID: 29898964. PMC6036230. https://www.ncbi.nlm.nih.gov/pubmed/29898964.

20. Horwitz SM, Ansell SM, Ai WZ, et al. Nccn Guidelines Insights: T-Cell Lymphomas, Version 2.2018. J Natl Compr Canc Netw. 2018;16(2):123-135. PMID: 29439173. https://www.ncbi.nlm.nih.gov/pubmed/29439173.

21. Janapati S, Wurtzel J, Dangelmaier C, et al. Tc21/Rras2 Regulates Glycoprotein Vi-Fcrgamma-Mediated Platelet Activation and Thrombus Stability. J Thromb Haemost. 2018. PMID: 29883056.
https://www.ncbi.nlm.nih.gov/pubmed/29883056.

22. Jordan SE, Micaily I, Hernandez E, et al. Image-Guided High-Dose-Rate Intracavitary Brachytherapy in the Treatment of Medically Inoperable Early-Stage Endometrioid Type Endometrial Adenocarcinoma. Brachytherapy. 2017;16(6):1144-1151. PMID: 28958736. https://www.ncbi.nlm.nih.gov/pubmed/28958736.

23. Joshi SS, Handorf EA, Zibelman M, et al. Treatment Facility Volume and Survival in Patients with Metastatic Renal Cell Carcinoma: A Registry-Based Analysis. Eur Urol. 2018. PMID: 29880274.
https://www.ncbi.nlm.nih.gov/pubmed/29880274.

24. Kluetz PG, Kanapuru B, Lemery S, et al. Informing the Tolerability of Cancer Treatments Using Patient-Reported Outcome Measures: Summary of an Fda and Critical Path Institute Workshop. Value Health. 2018;21(6):742-747. PMID: 29909880. https://www.ncbi.nlm.nih.gov/pubmed/29909880.

25. Kumar S, Konikoff C, Sanderford M, et al. Flyexpress 7: An Integrated Discovery Platform to Study Coexpressed Genes Using in Situ Hybridization Images in Drosophila. G3 (Bethesda). 2017;7(8):2791-2797. PMID: 28667017. PMC5555482. https://www.ncbi.nlm.nih.gov/pubmed/28667017.

26. Lamb EP, Pritchard FE, Nouer SS, et al. Understanding Disparities in Breast Cancer Care in Memphis, Tennessee. Am Surg. 2018;84(5):620-627. PMID: 29966559. https://www.ncbi.nlm.nih.gov/pubmed/29966559.

27. Lamb EP, Shaw FR, Fleming MD. Investigation of the Diagnostic Precision and Utility of Sentinel Lymph Node Biopsy in the Treatment of Patients with Merkel Cell Carcinoma. Am Surg. 2018;84(5):173-175. PMID: 29966556.
https://www.ncbi.nlm.nih.gov/pubmed/29966556.

28. Lepore SJ, Collins BN, Coffman DL, et al. Kids Safe and Smokefree (Kiss) Multilevel Intervention to Reduce Child Tobacco Smoke Exposure: Long-Term Results of a Randomized Controlled Trial. Int J Environ Res Public Health. 2018;15(6). PMID: 29895740. PMC6025102.
https://www.ncbi.nlm.nih.gov/pubmed/29895740.

29. Lewis-Wambi JS, Kim HR, Wambi C, et al. Correction To: Buthionine Sulfoximine Sensitizes Antihormone-Resistant Human Breast Cancer Cells to Estrogen-Induced Apoptosis. Breast Cancer Res. 2018;20(1):57. PMID: 29903038. PMC6003045. https://www.ncbi.nlm.nih.gov/pubmed/29903038.

30. Lim C, Cohn JR, Cohn JA. Can a Diagnosis of Bladder Cancer Motivate Positive Lifestyle Changes-and Prevent Recurrent Disease? Transl Androl Urol. 2018;7(Suppl 2):S242-S245. PMID: 29928624. PMC5989117.
https://www.ncbi.nlm.nih.gov/pubmed/29928624.

31. Lubner S, Feng Y, Mulcahy M, et al. E4206: Amg 706 and Octreotide in Patients with Low-Grade Neuroendocrine Tumors. Oncologist. 2018. PMID: 29853660. https://www.ncbi.nlm.nih.gov/pubmed/29853660.

32. Lukka HR, Pugh SL, Bruner DW, et al. Patient Reported Outcomes in Nrg Oncology Rtog 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate Cancer. Int J Radiat Oncol Biol Phys. 2018. PMID: 29913254.
https://www.ncbi.nlm.nih.gov/pubmed/29913254.

33. Masselli E, Carubbi C, Cambo B, et al. The -2518 a/G Polymorphism of the Monocyte Chemoattractant Protein-1 as a Candidate Genetic Predisposition Factor for Secondary Myelofibrosis and Biomarker of Disease Severity. Leukemia. 2018:1-4. PMID: 29568096. https://www.ncbi.nlm.nih.gov/pubmed/29568096.

34. Miura S, Gomez K, Murillo O, et al. Predicting Clone Genotypes from Tumor Bulk Sequencing of Multiple Samples. Bioinformatics. 2018. PMID: 29931046. https://www.ncbi.nlm.nih.gov/pubmed/29931046.

35. Myers VD, McClung JM, Wang J, et al. The Multifunctional Protein Bag3: A Novel Therapeutic Target in Cardiovascular Disease. JACC Basic Transl Sci. 2018;3(1):122-131. PMID: 29938246. PMC6013050. NIHMS949382.
https://www.ncbi.nlm.nih.gov/pubmed/29938246.

36. Nguyen JL, Heckman C, Perna F. Analysis of the Twitter “Don’t Fry Day” Campaign. JAMA Dermatol. 2018. PMID: 29926080. https://www.ncbi.nlm.nih.gov/pubmed/29926080.
37. Podszywalow-Bartnicka P, Maifrede S, Le BV, Nieborowska-Skorska M, Piwocka K, Skorski T. Parp1 Inhibitor Eliminated Imatinib-Refractory Chronic Myeloid Leukemia Cells in Bone Marrow Microenvironment Conditions. Leuk Lymphoma. 2018:1-3. PMID: 29932782.
https://www.ncbi.nlm.nih.gov/pubmed/29932782.

38. Pourfarhangi KE, De La Hoz EC, Cohen AR, Gligorijevic B. Contact Guidance Is Cell Cycle-Dependent. APL Bioeng. 2018;2(3). PMID: 29911682. PMC5997297. NIHMS971860.
https://www.ncbi.nlm.nih.gov/pubmed/29911682.

39. Prudnikova TY, Chernoff J. The Group I Pak Inhibitor Frax-1036 Sensitizes 11q13-Amplified Ovarian Cancer Cells to the Cytotoxic Effects of Rottlerin. Small GTPases. 2017;8(4):193-198. PMID: 27427770. PMC5680705.
https://www.ncbi.nlm.nih.gov/pubmed/27427770.

40. Punglia RS, Jiang W, Lipsitz SR, et al. Clinical Risk Score to Predict Likelihood of Recurrence after Ductal Carcinoma in Situ Treated with Breast-Conserving Surgery. Breast Cancer Res Treat. 2018;167(3):751-759. PMID: 29079937. https://www.ncbi.nlm.nih.gov/pubmed/29079937.

41. Ralff MD, El-Deiry WS. Trail Pathway Targeting Therapeutics. Expert Review of Precision Medicine and Drug Development. 2018;3(3):197-204.

42. Reichert M, Bakir B, Moreira L, et al. Regulation of Epithelial Plasticity Determines Metastatic Organotropism in Pancreatic Cancer. Dev Cell. 2018;45(6):696-711 e698. PMID: 29920275. PMC6011231. NIHMS974111.
https://www.ncbi.nlm.nih.gov/pubmed/29920275.

43. Sandler KA, Cook RR, Ciezki JP, et al. Clinical Outcomes for Patients with Gleason Score 10 Prostate Adenocarcinoma: Results from a Multi-Institutional Consortium Study. Int J Radiat Oncol Biol Phys. 2018;101(4):883-888. PMID: 29976500. https://www.ncbi.nlm.nih.gov/pubmed/29976500.

44. Scannell Bryan M, Argos M, Andrulis IL, et al. Germline Variation and Breast Cancer Incidence: A Gene-Based Association Study and Whole-Genome Prediction of Early Onset Breast Cancer. Cancer Epidemiol Biomarkers Prev. 2018. PMID: 29898891. https://www.ncbi.nlm.nih.gov/pubmed/29898891.

45. Sementino E, Menges CW, Kadariya Y, et al. Inactivation of Tp53 and Pten Drives Rapid Development of Pleural and Peritoneal Malignant Mesotheliomas. J Cell Physiol. 2018. PMID: 29904909.
https://www.ncbi.nlm.nih.gov/pubmed/29904909.

46. Shah MH, Goldner WS, Halfdanarson TR, et al. Nccn Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018. J Natl Compr Canc Netw. 2018;16(6):693-702. PMID: 29891520.
https://www.ncbi.nlm.nih.gov/pubmed/29891520.

47. Simons-Linares CR, Barkin JA, Wang Y, et al. Is There an Effect of Cannabis Consumption on Acute Pancreatitis? Dig Dis Sci. 2018. PMID: 29922897. https://www.ncbi.nlm.nih.gov/pubmed/29922897.

48. Sullivan-Reed K, Bolton-Gillespie E, Dasgupta Y, et al. Simultaneous Targeting of Parp1 and Rad52 Triggers Dual Synthetic Lethality in Brca-Deficient Tumor Cells. Cell Rep. 2018;23(11):3127-3136. PMID: 29898385.
https://www.ncbi.nlm.nih.gov/pubmed/29898385.

49. Tamura K, Tao Q, Kumar S. Theoretical Foundation of the Reltime Method for Estimating Divergence Times from Variable Evolutionary Rates. Mol Biol Evol. 2018;35(7):1770-1782. PMID: 29893954. PMC5995221.
https://www.ncbi.nlm.nih.gov/pubmed/29893954.

50. Virtue SM, Manne SL, Criswell K, Kissane D, Heckman CJ, Rotter D. Levels of Emotional Awareness During Psychotherapy among Gynecologic Cancer Patients. Palliat Support Care. 2018:1-8. PMID: 29880065.
https://www.ncbi.nlm.nih.gov/pubmed/29880065.

51. Wagner J, Kline CL, Zhou L, et al. Dose Intensification of Trail-Inducing Onc201 Inhibits Metastasis and Promotes Intratumoral Nk Cell Recruitment. J Clin Invest. 2018;128(6):2325-2338. PMID: 29533922. PMC5983321.
https://www.ncbi.nlm.nih.gov/pubmed/29533922.

52. Walker EA. A Prospective Evaluation of Drug Discrimination in Pharmacology. Curr Top Behav Neurosci. 2018. PMID: 29959754.
https://www.ncbi.nlm.nih.gov/pubmed/29959754.

53. Warner WA, Lee TY, Fang F, et al. The Burden of Prostate Cancer in Trinidad and Tobago: One of the Highest Mortality Rates in the World. Cancer Causes Control. 2018;29(7):685-697. PMID: 29774450. PMC5999193.
https://www.ncbi.nlm.nih.gov/pubmed/29774450.

54. Winer A, Adams S, Mignatti P. Matrix Metalloproteinase Inhibitors in Cancer Therapy: Turning Past Failures into Future Successes. Mol Cancer Ther. 2018;17(6):1147-1155. PMID: 29735645. PMC5984693.
https://www.ncbi.nlm.nih.gov/pubmed/29735645.

55. Wong E, Xu RH, Rubio D, et al. Migratory Dendritic Cells, Group 1 Innate Lymphoid Cells, and Inflammatory Monocytes Collaborate to Recruit Nk Cells to the Virus-Infected Lymph Node. Cell Rep. 2018;24(1):142-154. PMID: 29972776. https://www.ncbi.nlm.nih.gov/pubmed/29972776.

56. Wu L, Shi W, Long J, et al. A Transcriptome-Wide Association Study of 229,000 Women Identifies New Candidate Susceptibility Genes for Breast Cancer. Nat Genet. 2018. PMID: 29915430.
https://www.ncbi.nlm.nih.gov/pubmed/29915430.

57. Xiao C, Moughan J, Movsas B, et al. Risk Factors for Late Bowel and Bladder Toxicities in Nrg Oncology Prostate Cancer Trials of High-Risk Patients: A Meta-Analysis of Physician-Rated Toxicities. Adv Radiat Oncol. 2018.
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85048093122&doi=10.1016%2fj.adro.2018.04.010&partnerID=40&md5=c013afb83ab4cdae86194858a8f8d139.

58. Zeng H, Nanayakkara GK, Shao Y, et al. DNA Checkpoint and Repair Factors Are Nuclear Sensors for Intracellular Organelle Stresses-Inflammations and Cancers Can Have High Genomic Risks. Front Physiol. 2018;9:516. PMID: 29867559. PMC5958474. https://www.ncbi.nlm.nih.gov/pubmed/29867559.

59. Zhang D, Wang B, Zhang G, Ma C, Deng X. Comparison of 3d and 2d Gamma Passing Rate Criteria for Detection Sensitivity to Imrt Delivery Errors. J Appl Clin Med Phys. 2018;19(4):230-238. PMID: 29905004. PMC6036388.
https://www.ncbi.nlm.nih.gov/pubmed/29905004.

60. Zhang Y, Xiang J, Han Y, et al. Initial Experience of Robot-Assisted Ivor-Lewis Esophagectomy: 61 Consecutive Cases from a Single Chinese Institution. Dis Esophagus. 2018. PMID: 29873693.
https://www.ncbi.nlm.nih.gov/pubmed/29873693.

Advertisements

Staff Publications: May 2018

1. Anari F, Ramamurthy C, Zibelman M. Impact of Tumor Microenvironment Composition on Therapeutic Responses and Clinical Outcomes in Cancer. Future Oncol. 2018. PMID: 29848096.

2. Bauman JR, Schleicher SM, Nipp R, et al. Enhancing Communication between Oncology Care Providers and Patient Caregivers During Hospice. Journal of Community and Supportive Oncology. 2018;16(2):e72-e80.

3. Beck TN, Kharin LV, Kit OI, Dulaimi E, Boumber Y. Miliary Adenocarcinoma of the Lung Responds to Gefitinib and Afatinib. J Thorac Oncol. 2018;13(6):e95-e97. PMID: 29793652. Letter.

4. Berry KE. Estimating Fluoroscopic Peak Skin Dose Using Manual Calculations. Health Physics. 2018;114(6):649-653. WOS:000431514100008.

5. Bertolo R, Autorino R, Simone G, et al. Outcomes of Robot-Assisted Partial Nephrectomy for Clinical T2 Renal Tumors: A Multicenter Analysis (Rosula Collaborative Group). Eur Urol. 2018. PMID: 29784191.

6. Bevelacqua JJ, Mortazavi SMJ. Commentary: Human Pathophysiological Adaptations to the Space Environment. Frontiers in Physiology. 2018;8(JAN). PMID: Comment.

7. Blass BE, Iyer P, Abou-Gharbia M, et al. Design and Synthesis of Functionalized Piperazin-1yl-(E)-Stilbenes as Inhibitors of 17alpha-Hydroxylase-C17,20-Lyase (Cyp17). Bioorg Med Chem Lett. 2018. PMID: 29803730.

8. Borrero LJH, Sikder R, Lulla A, et al. Bcl-2 Protein Targeting by the P53/P21 Complex-Letter. Cancer Res. 2018;78(10):2770-2771. WOS:000432317900027. Letter.

9. Calvo E, Azaro A, Rodon J, et al. Hepatic Safety Analysis of Trabectedin: Results of a Pharmacokinetic Study with Trabectedin in Patients with Hepatic Impairment and Experience from a Phase 3 Clinical Trial. Investigational New Drugs. 2018;36(3):476-486. WOS:000431954900014.

10. Churilla TM, Weiss SE. Emerging Trends in the Management of Brain Metastases from Non-Small Cell Lung Cancer. Curr Oncol Rep. 2018;20(7):54. PMID: 29736685.

11. Colevas AD, Yom SS, Pfister DG, et al. Nccn Guidelines Insights: Head and Neck Cancers, Version 1.2018. J Natl Compr Canc Netw. 2018;16(5):479-490. PMID: 29752322.

12. Cui D, Zhang BW, Matubayasi N, Levy RM. The Role of Interfacial Water in Protein-Ligand Binding: Insights from the Indirect Solvent Mediated Potential of Mean Force. J Chem Theory Comput. 2018;14(2):512-526. PMID: 29262255. PMC5897112. NIHMS955674.

13. Cuttler JM, Mortazavi SMJ, Welsh JS, Doss M. Re: “Low-Dose Childhood Radiation Effects to the Thyroid Follow a Linear Dose-Response Trend and Persist Even 45+ Years after Exposure” (Clin Thyroidol 2017;29:235-236). Thyroid. 2018;28(5):679-680. PMID: Letter.

14. Di Meco A, Li JG, Barrero C, Merali S, Pratico D. Elevated Levels of Brain Homocysteine Directly Modulate the Pathological Phenotype of a Mouse Model of Tauopathy. Mol Psychiatry. 2018. PMID: 29728702.

15. Doss M. Selective Focus on Rare Hematologic Malignancies Misleads Risk-Benefit Assessment of Radioiodine Therapy of Thyroid Cancer. J Clin Oncol. 2018:Jco2018780981. PMID: 29723093.

16. Eilam-Frenkel B, Naaman H, Berkik G, et al. Microrna 146-5p, Mir-Let-7c-5p, Mir-221 and Mir-345-5p Are Differentially Expressed in Respiratory Syncytial Virus (Rsv) Persistently Infected Hep-2 Cells. Virus Res. 2018;251:34-39. PMID: 29733865.

17. Fanale MA, Horwitz SM, Forero-Torres A, et al. Five-Year Outcomes for Frontline Brentuximab Vedotin with Chp for Cd30-Expressing Peripheral T-Cell Lymphomas. Blood. 2018;131(19):2120-2124. WOS:000431897600006.

18. Feliciano JL, Le-Rademacher JG, Gajra A, et al. Do Older Patients with Non-Small Cell Lung Cancer Also Benefit from First-Line Platinum-Based Doublet Chemotherapy? Observations from a Pooled Analysis of 730 Prospectively-Treated Patients (Alliance Study A151622). J Geriatr Oncol. 2018. PMID: 29848457.

19. Frost CJ, Andrulis IL, Buys SS, et al. Assessing Patient Readiness for Personalized Genomic Medicine. J Community Genet. 2018. PMID: 29804257.

20. Fu X, Ju J, Lin Z, et al. Target Deletion of Complement Component 9 Attenuates Antibody-Mediated Hemolysis and Lipopolysaccharide (Lps)-Induced Acute Shock in Mice. Sci Rep. 2016;6:30239. PMID: 27444648. PMC4957234.

21. Gabbasov R, Xiao F, Howe CG, et al. Nedd9 Promotes Oncogenic Signaling, a Stem/Mesenchymal Gene Signature, and Aggressive Ovarian Cancer Growth in Mice. Oncogene. 2018. PMID: 29773902.

22. Gerson JN, Ramamurthy C, Borghaei H. Managing Adverse Effects of Immunotherapy. Clin Adv Hematol Oncol. 2018;16(5):364-374. PMID: 29851932.

23. Gettinger S, Hellmann MD, Chow LQM, et al. Nivolumab Plus Erlotinib in Patients with Epidermal Growth Factor Receptor-Mutant Advanced Non-Squamous Non-Small Cell Lung Cancer. J Thorac Oncol. 2018. PMID: 29802888.

24. Giroux V, Stephan J, Chatterji P, et al. Mouse Intestinal Krt15+ Crypt Cells Are Radio-Resistant and Tumor Initiating. Stem Cell Reports. 2018. PMID: 29805107.

25. Goodwin RD, Cheslack-Postava K, Santoscoy S, et al. Trends in Cannabis and Cigarette Use among Parents with Children at Home: 2002 to 2015. Pediatrics. 2018. PMID: 29759986.

26. Kapoor E, Benrubi D, Faubion SS. Menopausal Hormone Therapy in Gynecologic Cancer Survivors: A Review of the Evidence and Practice Recommendations. Clin Obstet Gynecol. 2018. PMID: 29762148.

27. Koczwara B, Stover AM, Davies L, et al. Harnessing the Synergy between Improvement Science and Implementation Science in Cancer: A Call to Action. J Oncol Pract. 2018:Jop1700083. PMID: 29750579.

28. Koh WJ, Abu-Rustum NR, Bean S, et al. Uterine Neoplasms, Version 1.2018: Clinical Practice Guidelines in Oncology. JNCCN Journal of the National Comprehensive Cancer Network. 2018;16(2):170-199.

29. Kumar S, Stecher G, Li M, Knyaz C, Tamura K. Mega X: Molecular Evolutionary Genetics Analysis across Computing Platforms. Mol Biol Evol. 2018;35(6):1547-1549. PMID: 29722887.

30. Kumar SK, Callander NS, Alsina M, et al. Multiple Myeloma, Version 3.2018: Featured Updates to the Nccn Guidelines. JNCCN Journal of the National Comprehensive Cancer Network. 2018;16(1):11-20.

31. Lee MH, Chakhtoura M, Sriram U, Caricchio R, Gallucci S. Conventional Dcs from Male and Female Lupus-Prone B6.Nzm Sle1/Sle2/Sle3 Mice Express an Ifn Signature and Have a Higher Immunometabolism That Are Enhanced by Estrogen. J Immunol Res. 2018;2018:1601079. PMID: 29850618. PMC5925037.

32. Li X, Wang L, Fang P, et al. Lysophospholipids Induce Innate Immune Transdifferentiation of Endothelial Cells, Resulting in Prolonged Endothelial Activation. J Biol Chem. 2018. PMID: 29769317.

33. Liang H, Zhou G, Ge Y, et al. Elucidating the Inhibition of Peptidoglycan Biosynthesis in Staphylococcus Aureus by Albocycline, a Macrolactone Isolated from Streptomyces Maizeus. Bioorg Med Chem. 2018. PMID: 29805074.

34. Lindsay T, Movva S. Role of Molecular Profiling in Soft Tissue Sarcoma. J Natl Compr Canc Netw. 2018;16(5):564-571. PMID: 29752329.

35. Liu H, Kiseleva AA, Golemis EA. Ciliary Signalling in Cancer. Nat Rev Cancer. 2018. PMID: 29802351.

36. Liu H, Sun Q, Sun Y, et al. Melk and Ezh2 Cooperate to Regulate Medulloblastoma Cancer Stem-Like Cell Proliferation and Differentiation. Mol Cancer Res. 2017;15(9):1275-1286. PMID: 28536141.

37. Ma GX, Shive SE, Zhang G, et al. Evaluation of a Healthy Chinese Take-out Sodium-Reduction Initiative in Philadelphia Low-Income Communities and Neighborhoods. Public Health Rep. 2018:33354918773747. PMID: 29846132.

38. Maifrede S, Nieborowska-Skorska M, Sullivan K, et al. Tyrosine Kinase Inhibitor-Induced Defects in DNA Repair Sensitize Flt3(Itd)-Positive Leukemia Cells to Parp1 Inhibitors. Blood. 2018. PMID: 29784639.

39. Manne S, Kashy DA, Zaider T, et al. Interpersonal Processes and Intimacy among Men with Localized Prostate Cancer and Their Partners. J Fam Psychol. 2018. PMID: 29771551.

40. Mei L, Du W, Idowu M, von Mehren M, Boikos SA. Advances and Challenges on Management of Gastrointestinal Stromal Tumors. Frontiers in Oncology. 2018;8. WOS:000431478900001.

41. Morrison C, Pabla S, Conroy JM, et al. Predicting Response to Checkpoint Inhibitors in Melanoma Beyond Pd-L1 and Mutational Burden. J Immunother Cancer. 2018;6(1):32. PMID: 29743104. PMC5944039.

42. Mortazavi SMJ. Comment on ‘Domestic Light at Night and Breast Cancer Risk: A Prospective Analysis of 105 000 Uk Women in the Generations Study’. Br J Cancer. 2018. PMID: 29769746. Letter.

43. Mortazavi SMJ. Comments on “Radiological Protection for Pregnant Women at a Large Academic Medical Cancer Center”. Physica Medica. 2018;47:144.

44. Moten AS, Lango MN, Goel N, Goldberg AJ. Regional Diagnostic Rates, Treatments, and Outcomes among Patients with Invasive Ductal Carcinoma. Journal of Surgical Research. 2018;229:114-121.

45. Mukherjee S, Pantelopulos GA, Voelz VA. Markov Models of the Apo-Mdm2 Lid Region Reveal Diffuse yet Two-State Binding Dynamics and Receptor Poses for Computational Docking. Sci Rep. 2016;6:31631. PMID: 27538695. PMC4990920.

46. Oliver JS, Allen RS, Eichorst MK, et al. A Pilot Study of Prostate Cancer Knowledge among African American Men and Their Health Care Advocates: Implications for Screening Decisions. Cancer Causes Control. 2018. PMID: 29804218.

47. Pang M, Bartel MJ, Brand EC, et al. Outcome of Long Benign Esophageal Strictures Undergoing Endoscopictherapy: A Tertiary Center Experience. Dis Esophagus. 2018. PMID: 29718161.

48. Patel NR, Piroyan A, Ganta S, et al. In Vitro and in Vivo Evaluation of a Novel Folate-Targeted Theranostic Nanoemulsion of Docetaxel for Imaging and Improved Anticancer Activity against Ovarian Cancers. Cancer Biol Ther. 2018;19(7):554-564. PMID: 29737910.

49. Patel R, Scheinfeldt LB, Sanderford MD, et al. Adaptive Landscape of Protein Variation in Human Exomes. Mol Biol Evol. 2018. PMID: 29846678.

50. Patel SA, Ng M, Nardello SM, Ruth K, Bleicher RJ. Immediate Breast Reconstruction for Women Having Inflammatory Breast Cancer in the United States. Cancer Med. 2018. PMID: 29761885.

51. Ristau BT, Manola J, Haas NB, et al. Retroperitoneal Lymphadenectomy for High Risk, Nonmetastatic Renal Cell Carcinoma: An Analysis of the Assure (Ecog-Acrin 2805) Adjuvant Trial. Journal of Urology. 2018;199(1):53-59.

52. Ristau BT, Smaldone MC. Editorial Comment. Journal of Urology. 2018;199(4):914.

53. Santucci-Pereira J, Pogash TJ, Patel A, et al. Aspirin Abrogates Impairment of Mammary Gland Differentiation Induced by Early in Life Second-Hand Smoke in Mice. Carcinogenesis. 2018. PMID: 29788174.

54. Saxon B, Bass SB, Wright T, Panick J. Ebola and the Rhetoric of US Newspapers: Assessing Quality Risk Communication in Public Health Emergencies. Journal of Risk Research. 2018:1-14.

55. Schuetze SM, Bolejack V, Thomas DG, et al. Association of Dasatinib with Progression-Free Survival among Patients with Advanced Gastrointestinal Stromal Tumors Resistant to Imatinib. JAMA Oncol. 2018. PMID: 29710216.

56. Shah PH, Alom MA, Leibovich BC, et al. The Temporal Association of Robotic Surgical Diffusion with Overtreatment of the Small Renal Mass. J Urol. 2018. PMID: 29792881.

57. Shi XF, Ba R, You HY, et al. A Rare Case of B-Lymphoproliferative Disorder with Villous Lymphocytes Harboring T(8;14)(Q24;Q32) Translocation. Frontiers of Medicine. 2018;12(3):324-329. WOS:000432336500010.

58. Siminoff LA, Wilson-Genderson M, Gardiner HM, Mosavel M, Barker KL. Consent to a Postmortem Tissue Procurement Study: Distinguishing Family Decision Makers’ Knowledge of the Genotype-Tissue Expression Project. Biopreserv Biobank. 2018. PMID: 29746160.

59. Sun M, Marconi L, Eisen T, et al. Adjuvant Vascular Endothelial Growth Factor-Targeted Therapy in Renal Cell Carcinoma: A Systematic Review and Pooled Analysis. Eur Urol. 2018. PMID: 29784193.

60. Sun Y, Johnson C, Zhou J, et al. Uremic Toxins Are Conditional Danger- or Homeostasis-Associated Molecular Patterns. Front Biosci (Landmark Ed). 2018;23:348-387. PMID: 28930551. PMC5627515. NIHMS907864.

61. Tan CRC, Abdul-Majeed S, Cael B, Barta SK. Clinical Pharmacokinetics and Pharmacodynamics of Bortezomib. Clin Pharmacokinet. 2018. PMID: 29802543.

62. Tang B, Lee HO, An SS, Cai KQ, Kruger WD. Specific Targeting of Mtap-Deleted Tumors with a Combination of 2′-Fluoroadenine and 5′-Methylthioadenosine. Cancer Res. 2018. PMID: 29844120.

63. Timmerman RD, Paulus R, Pass HI, et al. Stereotactic Body Radiation Therapy for Operable Early-Stage Lung Cancer: Findings from the Nrg Oncology Rtog 0618 Trial. JAMA Oncol. 2018. PMID: 29852037.

64. von Massenhausen A, Tonnus W, Himmerkus N, et al. Correction To: Phenytoin Inhibits Necroptosis. Cell Death Dis. 2018;9(6):622. PMID: 29795371. PMC5967310.
65. von Mehren M, Randall RL, Benjamin RS, et al. Soft Tissue Sarcoma, Version 2.2018. Journal of the National Comprehensive Cancer Network. 2018;16(5):536-563. WOS:000431928700012.

66. Vyfhuis MAL, Bhooshan N, Molitoris J, et al. Corrigendum to “Clinical Outcomes of Black Vs. Non-Black Patients with Locally Advanced Non–Small Cell Lung Cancer” [Lung Cancer 114, (December 2017) 44–49] (S016950021730555x) (10.1016/J.Lungcan.2017.10.016)). Lung Cancer. 2018;116:105.

67. Warner WA, Lee TY, Fang F, et al. The Burden of Prostate Cancer in Trinidad and Tobago: One of the Highest Mortality Rates in the World. Cancer Causes Control. 2018. PMID: 29774450.

68. Whelan KA, Muir AB, Nakagawa H. Esophageal 3d Culture Systems as Modeling Tools in Esophageal Epithelial Pathobiology and Personalized Medicine. Cell Mol Gastroenterol Hepatol. 2018;5(4):461-478. PMID: 29713660. PMC5924738.

69. Wong YN, Manola J, Hudes GR, et al. Phase 2 Study of Weekly Paclitaxel Plus Estramustine in Metastatic Hormone-Refractory Prostate Carcinoma: Ecog-Acrin Cancer Research Group (E1898) Trial. Clin Genitourin Cancer. 2018;16(2):e315-e322.

70. Zarin P, In TSH, Chen ELY, et al. Integration of T Cell Receptor, Notch and Cytokine Signals Programs in Mouse Gammadelta T Cell Effector Differentiation. Immunol Cell Biol. 2018. PMID: 29754419.

Staff Publications: April 2018

1. Abbas AM, Strong AT, Diehl DL, et al. Multicenter Evaluation of the Clinical Utility of Laparoscopy-Assisted Ercp in Patients with Roux-En-Y Gastric Bypass. Gastrointestinal Endoscopy. 2018;87(4):1031-1039.

2. Adolf-Bryfogle J, Kalyuzhniy O, Kubitz M, et al. Rosettaantibodydesign (Rabd): A General Framework for Computational Antibody Design. PLoS Comput Biol. 2018;14(4):e1006112. PMID: 29702641.

3. Autieri MV. Il-19 and Other Il-20 Family Member Cytokines in Vascular Inflammatory Diseases. Front Immunol. 2018;9:700. PMID: 29681905. PMC5897441.
4. Benson AB, 3rd, Venook AP, Al-Hawary MM, et al. Nccn Guidelines Insights: Colon Cancer, Version 2.2018. J Natl Compr Canc Netw. 2018;16(4):359-369. PMID: 29632055.

5. Borghaei H, Yim YM, Guerin A, et al. Severe Adverse Events Impact Overall Survival and Costs in Elderly Patients with Advanced Non-Small Cell Lung Cancer on Second-Line Therapy. Lung Cancer. 2018;119:112-119. PMID: 29656745.

6. Cahn DB, Foote C, Smaldone MC. Challenges Facing Regionalization of Radical Cystectomy. Translational Andrology and Urology. 2018;7(2):292-294.

7. Cohen SJ, Zalupski MM, Conkling P, et al. A Phase 2 Randomized, Double-Blind, Multicenter Trial of Imexon Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients with Metastatic Chemotherapy-Naive Pancreatic Adenocarcinoma. American Journal of Clinical Oncology-Cancer Clinical Trials. 2018;41(3):230-235.

8. Correa AF, Smaldone MC. Melancholia and Cancer: The Bladder Cancer Narrative. Cancer. 2018. PMID: 29660788.

9. Cueto R, Zhang L, Shan HM, et al. Identification of Homocysteine-Suppressive Mitochondrial Etc Complex Genes and Tissue Expression Profile – Novel Hypothesis Establishment. Redox Biol. 2018;17:70-88. PMID: 29679893.

10. Dolman GE, Koffas A, Mason WS, Kennedy PT. Why, Who and When to Start Treatment for Chronic Hepatitis B Infection. Curr Opin Virol. 2018;30:39-47. PMID: 29655092.
11. Doss M. Radiation Dose from Cardiac Catheterization Procedures in Young Patients May Not Contribute to Increased Cancer Risk. Eur J Epidemiol. 2018. PMID: 29616389.

12. Edwards DC, Cahn DB, Smaldone MC, Kutikov A. Use of Administrative Data for Comparative Effectiveness Research in the Treatment of Non-Prostate Genitourinary Malignancies. Urologic Oncology-Seminars and Original Investigations. 2018;36(4):193-212.

13. Fahl SP, Wiest DL. Reply to Chien: Clarification of the Effect of Ligand on Gammadelta-Tcr Repertoire Selection. Proc Natl Acad Sci U S A. 2018;115(16):E3607-e3608. PMID: 29615510. PMC5910880.

14. Gajra A, Zemla TJ, Jatoi A, et al. Time-to-Treatment-Failure and Related Outcomes among 1000+ Advanced Non-Small Cell Lung Cancer Patients: Comparisons between Older Versus Younger Patients (Alliance A151711). J Thorac Oncol. 2018. PMID: 29608967.

15. Geynisman DM, Meeker CR, Doyle JL, et al. Provider and Patient Burdens of Obtaining Oral Anticancer Medications. Am J Manag Care. 2018;24(4):e128-e133. PMID: 29668216.

16. Gianti E, Delemotte L, Klein ML, Carnevale V. On the Role of Water Density Fluctuations in the Inhibition of a Proton Channel. Proc Natl Acad Sci U S A. 2016;113(52):E8359-e8368. PMID: 27956641. PMC5206518.

17. Giri VN, Obeid E, Hegarty SE, et al. Understanding of Multigene Test Results among Males Undergoing Germline Testing for Inherited Prostate Cancer: Implications for Genetic Counseling. Prostate. 2018. PMID: 29655297.

18. Gray PN, Tsai P, Chen D, et al. Tumornext-Lynch-Mmr: A Comprehensive Next Generation Sequencing Assay for the Detection of Germline and Somatic Mutations in Genes Associated with Mismatch Repair Deficiency and Lynch Syndrome. Oncotarget. 2018;9(29):20304-20322.

19. Gu J, Maxwell AE, Ma GX, et al. Evaluating the Training of Chinese-Speaking Community Health Workers to Implement a Small-Group Intervention Promoting Mammography. J Cancer Educ. 2018. PMID: 29654506.

20. Hall TM, Tetreault MP, Hamilton KE, Whelan KA. Autophagy as a Cytoprotective Mechanism in Esophageal Squamous Cell Carcinoma. Curr Opin Pharmacol. 2018;41:12-19. PMID: 29677645.

21. Hassett MJ, Jiang W, Hughes ME, et al. Treating Second Breast Events after Breast-Conserving Surgery for Ductal Carcinoma in Situ. J Natl Compr Canc Netw. 2018;16(4):387-394. PMID: 29632058.

22. Heckman CJ, Handorf E, Auerbach MV. Prevalence and Correlates of Skin Cancer Screening among Indoor Tanners and Nontanners. JAMA Dermatol. 2018. PMID: 29617518.

23. Hellmann MD, Ciuleanu TE, Pluzanski A, et al. Nivolumab Plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden. N Engl J Med. 2018. PMID: 29658845.

24. Hellmann MD, Nathanson T, Rizvi H, et al. Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer. Cancer Cell. 2018. PMID: 29657128.

25. Hernandez Borrero LJ, Sikder R, Lulla A, et al. Bcl-2 Protein Targeting by the P53/P21 Complex-Letter. Cancer Res. 2018. PMID: 29703721.

26. Hernandez-Borrero LJ, Zhang S, Lulla A, Dicker DT, El-Deiry WS. Cb002, a Novel P53 Tumor Suppressor Pathway-Restoring Small Molecule Induces Tumor Cell Death through the Pro-Apoptotic Protein Noxa. Cell Cycle. 2018:1-11.

27. Houghton LC, Knight JA, De Souza MJ, et al. Comparison of Methods to Assess Onset of Breast Development in the Legacy Girls Study: Methodological Considerations for Studies of Breast Cancer. Breast Cancer Res. 2018;20(1):33. PMID: 29669587.

28. Ingram JP, Tursi S, Zhang T, et al. A Nonpyroptotic Ifn-Gamma-Triggered Cell Death Mechanism in Nonphagocytic Cells Promotes Salmonella Clearance in Vivo. J Immunol. 2018. PMID: 29654208.

29. Jalagadugula G, Goldfinger LE, Mao G, Lambert MP, Rao AK. Defective Rab1b-Related Megakaryocytic Er-to-Golgi Transport in Runx1 Haplodeficiency: Impact on Von Willebrand Factor. Blood Adv. 2018;2(7):797-806. PMID: 29632235. PMC5894258.

30. Jonasch E, Slack RS, Geynisman DM, et al. Phase Ii Study of Two Weeks on, One Week Off Sunitinib Scheduling in Patients with Metastatic Renal Cell Carcinoma. J Clin Oncol. 2018:Jco2017771485. PMID: 29641297.

31. Kaiser CE, Rincon Pabon JP, Khowsathit J, et al. Modulating Antibody Structure and Function through Directed Mutations and Chemical Rescue. ACS Synth Biol. 2018;7(4):1152-1162. PMID: 29609459. PMC5910032. NIHMS958000.

32. Kamboj M, Brite J, Aslam A, et al. Artificial Differences in Clostridium Difficile Infection Rates Associated with Disparity in Testing. Emerging Infectious Diseases. 2018;24(3):584-587.

33. Kasivisvanathan V, Kutikov A, Manning TG, et al. Safeguarding the Future of Urological Research and Delivery of Clinical Excellence by Harnessing the Power of Youth to Spearhead Urological Research. Eur Urol. 2018;73(5):645-647.

34. Kearns AC, Robinson JA, Shekarabi M, Liu F, Qin X, Burdo TH. Caspase-1-Associated Immune Activation in an Accelerated Siv-Infected Rhesus Macaque Model. J Neurovirol. 2018. PMID: 29611111.

35. Khatri NV, Patel B, Kohli DR, Solomon SS, Bull-Henry K, Kessler CM. Lenalidomide as a Novel Therapy for Gastrointestinal Angiodysplasia in Von Willebrand Disease. Haemophilia. 2018;24(2):278-282.

36. Kornblum N, Zhao F, Manola J, et al. Randomized Phase Ii Trial of Fulvestrant Plus Everolimus or Placebo in Postmenopausal Women with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Resistant to Aromatase Inhibitor Therapy: Results of Pre0102. J Clin Oncol. 2018:Jco2017769331. PMID: 29664714.

37. Kumar S, Patel R. Neutral Theory, Disease Mutations, and Personal Exomes. Mol Biol Evol. 2018. PMID: 29688514.

38. McIntosh AG, Ristau BT, Ruth K, et al. Active Surveillance for Localized Renal Masses: Tumor Growth, Delayed Intervention Rates, and >5-Yr Clinical Outcomes. Eur Urol. 2018. PMID: 29625756.

39. Mehrazin R, Dulaimi E, Uzzo RG, et al. The Correlation between Gain of Chromosome 8q and Survival in Patients with Clear and Papillary Renal Cell Carcinoma. Therapeutic Advances in Urology. 2018;10(1):3-10.

40. Mehren MV, Joensuu H. Gastrointestinal Stromal Tumors. Journal of Clinical Oncology. 2018;36(2):136-143.

41. Milano RV, Viale E, Bartel MJ, Notaristefano C, Testoni PA. Resection Outcomes and Recurrence Rates of Endoscopic Submucosal Dissection (Esd) and Hybrid Esd for Colorectal Tumors in a Single Italian Center. Surgical Endoscopy and Other Interventional Techniques. 2018;32(5):2328-2339.

42. Mishra OP, Popov AV, Pietrofesa RA, Nakamaru-Ogiso E, Andrake M, Christofidou-Solomidou M. Synthetic Secoisolariciresinol Diglucoside (Lgm2605) Inhibits Myeloperoxidase Activity in Inflammatory Cells. Biochimica et Biophysica Acta – General Subjects. 2018;1862(6):1364-1375.

43. Moore KN, Martin LP, O’Malley DM, et al. A Review of Mirvetuximab Soravtansine in the Treatment of Platinum-Resistant Ovarian Cancer. Future Oncology. 2018;14(2):123-136.

44. Morgans AK, Chen YH, Sweeney CJ, et al. Quality of Life During Treatment with Chemohormonal Therapy: Analysis of E3805 Chemohormonal Androgen Ablation Randomized Trial in Prostate Cancer. Journal of Clinical Oncology. 2018;36(11):1088-1095.

45. Mortazavi SMJ. Commentary: Geographic Variations in the Incidence of Glioblastoma and Prognostic Factors Predictive of Overall Survival in US Adults from 2004-2013. Frontiers in Aging Neuroscience. 2018;10.

46. Mortazavi SMJ. Comments on “Radiological Protection for Pregnant Women at a Large Academic Medical Cancer Center”. Physica Medica-European Journal of Medical Physics. 2018;47:144-144.

47. Mortazavi SMJ. Shortcomings of the Immunological Model of Carcinogenesis. Proc Natl Acad Sci U S A. 2018. PMID: 29669916.

48. Mortazavi SMJ, Mortazavi G. Re: Blood Mercury Concentration in Relation to Metabolic and Weight Phenotypes Using the Knhanes 2011-2013 Data. Int Arch Occup Environ Health. 2018;91(2):247. PMID: 29273973.

49. Peng H, Prokop J, Karar J, et al. Familial and Somatic Bap1 Mutations Inactivate Asxl1/2-Mediated Allosteric Regulation of Bap1 Deubiquitinase by Targeting Multiple Independent Domains. Cancer Res. 2018;78(5):1200-1213.

50. Perera M, Al-Hebshi NN, Perera I, et al. Inflammatory Bacteriome and Oral Squamous Cell Carcinoma. J Dent Res. 2018:22034518767118. PMID: 29630846.

51. Punglia RS, Jiang W, Lipsitz SR, et al. Clinical Risk Score to Predict Likelihood of Recurrence after Ductal Carcinoma in Situ Treated with Breast-Conserving Surgery. Breast Cancer Res Treat. 2017:1-9.

52. Ray M, Gabunia K, Vrakas CN, et al. Genetic Deletion of Il (Interleukin)-19 Exacerbates Atherogenesis in Il19(-/-) Xldlr(-/-) Double Knockout Mice by Dysregulation of Mrna Stability Protein Hur (Human Antigen R). Arterioscler Thromb Vasc Biol. 2018. PMID: 29674474.

53. Reese JB, Handorf E, Haythornthwaite JA. Sexual Quality of Life, Body Image Distress, and Psychosocial Outcomes in Colorectal Cancer: A Longitudinal Study. Support Care Cancer. 2018. PMID: 29679138.

54. Regine WF, Winter K, Abrams RA, et al. Postresection Ca19-9 and Margin Status as Predictors of Recurrence after Adjuvant Treatment for Pancreatic Carcinoma: Analysis of Nrg Oncology Rtog Trial 9704. Advances in Radiation Oncology. 2018;3(2):154-162.

55. Remakus S, Ma X, Tang L, et al. Cutting Edge: Protection by Antiviral Memory Cd8 T Cells Requires Rapidly Produced Antigen in Large Amounts. J Immunol. 2018. PMID: 29643193.

56. Ristau BT, Smaldone MC. Extended Venous Thromboembolism Prophylaxis after Radical Cystectomy: A Call for Adherence to Current Guidelines Editorial Comment. Journal of Urology. 2018;199(4):914-914.

57. Rudat S, Pfaus A, Cheng YY, et al. Ret-Mediated Autophagy Suppression as Targetable Co-Dependence in Acute Myeloid Leukemia. Leukemia. 2018. PMID: 29654265.

58. Shah T, Lippman R, Kohli D, Mutha P, Solomon S, Zfass A. Accuracy of Probe-Based Confocal Laser Endomicroscopy (Pcle) Compared to Random Biopsies During Endoscopic Surveillance of Barrett’s Esophagus. Endosc Int Open. 2018;6(4):E414-e420. PMID: 29607393. PMC5876024.

59. Smith EP, Li H, Friedberg JW, et al. Tandem Autologous Hematopoietic Cell Transplantation for Patients with Primary Progressive or Recurrent Hodgkin Lymphoma: A Swog and Blood and Marrow Transplant Clinical Trials Network Phase Ii Trial (Swog S0410/Bmt Ctn 0703). Biology of Blood and Marrow Transplantation. 2018;24(4):700-707.

60. Steffen LE, Vowles KE, Smith BW, Gan GN, Edelman MJ. Daily Diary Study of Hope, Stigma, and Functioning in Lung Cancer Patients. Health Psychology. 2018;37(3):218-227.

61. Thomson MD, Siminoff LA. Managing Work and Cancer Treatment: Experiences among Survivors of Hematological Cancer. Cancer. 2018. PMID: 29660822.

62. Ujjani C, Wang H, Skarbnik A, et al. A Phase 1 Study of Lenalidomide and Ibrutinib in Combination with Rituximab in Relapsed and Refractory Cll. Blood Adv. 2018;2(7):762-768. PMID: 29610115. PMC5894261.

63. Wang HH, Wu ZQ, Qian D, et al. Ablative Hypofractionated Radiation Therapy Enhances Non-Small Cell Lung Cancer Cell Killing Via Preferential Stimulation of Necroptosis in Vitro and in Vivo. Int J Radiat Oncol Biol Phys. 2018;101(1):49-62. PMID: 29619976.

64. Wolf SM, Scholtes E, Koenig BA, et al. Pragmatic Tools for Sharing Genomic Research Results with the Relatives of Living and Deceased Research Participants. Journal of Law Medicine & Ethics. 2018;46(1):87-109.

65. Wood DE, Kazerooni EA, Baum SL, et al. Lung Cancer Screening, Version 3.2018. Journal of the National Comprehensive Cancer Network. 2018;16(4):412-441. PMID: 29632061.

66. Yadav J, Korzekwa K, Nagar S. Improved Predictions of Drug-Drug Interactions Mediated by Time-Dependent Inhibition of Cyp3a. Mol Pharm. 2018. PMID: 29608318.

67. Zaorsky NG, Keith SW, Shaikh T, et al. Impact of Radiation Therapy Dose Escalation on Prostate Cancer Outcomes and Toxicities. Am J Clin Oncol. 2018;41(4):409-415. PMID: 27014930.

68. Zhang BW, Cui D, Matubayasi N, Levy RM. The Excess Chemical Potential of Water at the Interface with a Protein from End Point Simulations. J Phys Chem B. 2018. PMID: 29634902.

Staff Publications: March 2018

1. Aelion CM, Airhihenbuwa CO, Alemagno S, et al. The US Cancer Moonshot Initiative. Lancet Oncol. 2016;17(5):e178-180. PMID: 27301041. Letter.

2. Agarwal N, Pal SK, Hahn AW, et al. Characterization of Metastatic Urothelial Carcinoma Via Comprehensive Genomic Profiling of Circulating Tumor DNA. Cancer. 2018. PMID: 29517810.

3. Auerbach MV, Heckman CJ, Darlow S. To Protect or Not to Protect: Examining Reasons for Sun Protection among Young Women at Risk for Skin Cancer. J Behav Med. 2018. PMID: 29589257.

4. Bagrodia A, Woldu S, Penson DF, Kutikov A, Kaffenberger SD. Re: Sophia C. Kamran, Thomas Seisen, Sarah C. Markt, Et Al. Contemporary Treatment Patterns and Outcomes for Clinical Stage Is Testicular Cancer. Eur Urol 2018;73:262-70. European Urology. 2018;73(4):E98-E99. Letter.

5. Bayarmagnai B, Perrin L, Esmaeili Pourfarhangi K, Gligorijevic B. Intravital Imaging of Tumor Cell Motility in the Tumor Microenvironment Context. Methods Mol Biol. 2018;1749:175-193. PMID: 29525998.

6. Bevelacqua JJ, Welsh J, Mortazavi SMJ, Doss M. Comments on “Radiation Induced Breast Cancer Risk in Brca Mutation Carriers from Low-Dose Radiological Exposures: A Systematic Review”: Radioprotection 52(4), 231-240, Doi: 10.1051/Radiopro/2017034. Radioprotection. 2018;53(1):67-68.

7. Brown JR, Hamadani M, Hayslip J, et al. Voxtalisib (Xl765) in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukaemia: An Open-Label, Phase 2 Trial. Lancet Haematol. 2018;5(4):e170-e180. PMID: 29550382.

8. Buller DB, Heckman CJ, Manne SL. The Potential of Behavioral Counseling to Prevent Skin Cancer. JAMA Dermatol. 2018. PMID: 29558529.

9. Cartmell KB, Sterba KR, Pickett K, et al. Availability of Patient-Centered Cancer Support Services: A Statewide Survey of Cancer Centers. PLoS One. 2018;13(3):e0194649. PMID: 29584744.

10. Caruso LB, Martin KA, Lauretti E, et al. Poly(Adp-Ribose) Polymerase 1, Parp1, Modifies Ezh2 and Inhibits Ezh2 Histone Methyltransferase Activity after DNA Damage. Oncotarget. 2018;9(12):10585-10605. PMID: 29535829. PMC5828221.

11. Chen M, Zheng L, Santra B, et al. Hydroxide Diffuses Slower Than Hydronium in Water Because Its Solvated Structure Inhibits Correlated Proton Transfer. Nat Chem. 2018;10(4):413-419. PMID: 29531374.

12. Cheng Z, Shen X, Jiang X, et al. Hyperhomocysteinemia Potentiates Diabetes-Impaired Edhf-Induced Vascular Relaxation: Role of Insufficient Hydrogen Sulfide. Redox Biol. 2018;16:215-225. PMID: 29524844. PMC5854893.

13. Chhatre S, Jefferson A, Cook R, et al. Patient-Centered Recruitment and Retention for a Randomized Controlled Study. Trials. 2018;19(1):205. PMID: 29587805. PMC5870194.

14. Christopher Z, Binitie O, Henderson-Jackson E, Perno J, Makanji RJ. Langerhans Cell Histiocytosis of Bone in an Adult: A Case Report. Radiology Case Reports. 2018;13(2):310-314.

15. Correa AF, Handorf E, Joshi SS, et al. Differences in Survival Associated with Performance of Lymph Node Dissection in Patients with Invasive Penile Cancer: Results from the National Cancer Database. Journal of Urology. 2018.

16. Correa AF, Toussi A, Amin M, et al. Small Renal Masses in Close Proximity to the Collecting System and Renal Sinus Are Enriched for Malignancy and High Fuhrman Grade and Should Be Considered for Early Intervention. Clin Genitourin Cancer. 2018. PMID: 29500151.

17. Eskander RN, Kauderer J, Tewari KS, et al. Correlation between Surgeon’s Assessment and Radiographic Evaluation of Residual Disease in Women with Advanced Stage Ovarian Cancer Reported to Have Undergone Optimal Surgical Cytoreduction: An NRG Oncology/Gynecologic Oncology Group Study. Gynecol Oncol. 2018. PMID: 29550184.

18. Fareed MM, Ishtiaq R, Galloway TJ. Testing the Timing: Time Factor in Radiation Treatment for Head and Neck Cancers. Curr Treat Options Oncol. 2018;19(4):17. PMID: 29527638.

19. Forastiere AA, Fisher SG, Wolf GT. Reply to L. Licitra Et Al. J Clin Oncol. 2018:Jco2018778316. PMID: 29558279.

20. Ge Y, Voelz VA. Model Selection Using Biceps: A Bayesian Approach for Force Field Validation and Parameterization. J Phys Chem B. 2018. PMID: 29518328.

21. Gradishar WJ, Anderson BO, Balassanian R, et al. Breast Cancer, Version 4.2017 Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network. 2018;16(3):310-320.

22. Guo P, Xue HY, Wong HL. Therapeutic Nanotechnology for Bone Infection Treatment – State of the Art. Curr Drug Deliv. 2018. PMID: 29493453.

23. Hamilton ZA, Uzzo RG, Larcher A, et al. Comparison of Functional Outcomes of Robotic and Open Partial Nephrectomy in Patients with Pre-Existing Chronic Kidney Disease: A Multicenter Study. World J Urol. 2018. PMID: 29532222.

24. Heath EI, Lynce F, Xiu J, et al. Racial Disparities in the Molecular Landscape of Cancer. Anticancer Res. 2018;38(4):2235-2240. PMID: 29599344.

25. Hoppe RT, Advani RH, Ai WZ, et al. Nccn Guidelines Insights: Hodgkin Lymphoma, Version 1.2018. J Natl Compr Canc Netw. 2018;16(3):245-254. PMID: 29523663.

26. Hyman DM, Rizvi NA, Natale RB, et al. Phase I Study of Medi3617, a Selective Angiopoietin-2 Inhibitor Alone and Combined with Carboplatin/Paclitaxel, Paclitaxel, or Bevacizumab for Advanced Solid Tumors. Clin Cancer Res. 2018. PMID: 29559563.

27. Indio V, Astolfi A, Tarantino G, et al. Integrated Molecular Characterization of Gastrointestinal Stromal Tumors (Gist) Harboring the Rare D842v Mutation in Pdgfra Gene. Int J Mol Sci. 2018;19(3). PMID: 29510530.

28. Joshi SS, Handorf E, Strauss D, et al. Treatment Trends and Outcomes for Patients with Lymph Node-Positive Cancer of the Penis. JAMA Oncol. 2018. PMID: 29494739.

29. Kasagi Y, Chandramouleeswaran PM, Whelan KA, et al. The Esophageal Organoid System Reveals Functional Interplay between Notch and Cytokines in Reactive Epithelial Changes. Cell Mol Gastroenterol Hepatol. 2018;5(3):333-352. PMID: 29552622. PMC5852293.

30. Kelly AD, Madzo J, Madireddi P, et al. Demethylator Phenotypes in Acute Myeloid Leukemia. Leukemia. 2018. PMID: 29556023.

31. Khan N, Kahl B. Targeting Bcl-2 in Hematologic Malignancies. Target Oncol. 2018. PMID: 29520705.

32. Kim SM, Nguyen TT, Ravi A, et al. Pten Deficiency and Ampk Activation Promote Nutrient Scavenging and Anabolism in Prostate Cancer Cells. Cancer Discov. 2018. PMID: 29572236.

33. Kinde MN, Bondarenko V, Granata D, et al. Fluorine-19 Nmr and Computational Quantification of Isoflurane Binding to the Voltage-Gated Sodium Channel Nachbac. Proc Natl Acad Sci U S A. 2016;113(48):13762-13767. PMID: 27856739. PMC5137747.

34. Kishan AU, Cook RR, Ciezki JP, et al. Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy with Brachytherapy Boost and Disease Progression and Mortality in Patients with Gleason Score 9-10 Prostate Cancer. Jama. 2018;319(9):896-905. PMID: 29509865.

35. Klaassen Z, Arora K, Goldberg H, et al. Extended Venous Thromboembolism Prophylaxis after Radical Cystectomy: A Call for Adherence to Current Guidelines. Journal of Urology. 2018;199(4):906-914.

36. Lazar S, Goldfinger LE. Platelet Microparticles and Mirna Transfer in Cancer Progression: Many Targets, Modes of Action, and Effects across Cancer Stages. Front Cardiovasc Med. 2018;5:13. PMID: 29564336. PMC5850852.

37. Lev A, Lulla AR, Ross BC, et al. Onc201 Targets Ar and Ar-V7 Signaling, Reduces Psa, and Synergizes with Everolimus in Prostate Cancer. Mol Cancer Res. 2018. PMID: 29588330.

38. Li PX, Wong YN, Jahnke J, Pettit AR, Doshi JA. Association of High Cost Sharing and Targeted Therapy Initiation among Elderly Medicare Patients with Metastatic Renal Cell Carcinoma. Cancer Medicine. 2018;7(1):75-86.

39. Lucas JW, Ghiraldi E, Ellis J, Friedlander JI. Endoscopic Management of Ureteral Strictures: An Update. Curr Urol Rep. 2018;19(4):24. PMID: 29500521.

40. Lyu RM, Cowan A, Zhang Y, et al. Phoenixin: A Novel Brain-Gut-Skin Peptide with Multiple Bioactivity. Acta Pharmacol Sin. 2018. PMID: 29542680.

41. Makhov P, Naito S, Haifler M, et al. The Convergent Roles of Nf-Kappab and Er Stress in Sunitinib-Mediated Expression of Pro-Tumorigenic Cytokines and Refractory Phenotype in Renal Cell Carcinoma. Cell Death Dis. 2018;9(3):374. PMID: 29515108. PMC5841329.

42. Masselli E, Carubbi C, Cambo B, et al. The -2518 a/G Polymorphism of the Monocyte Chemoattractant Protein-1 as a Candidate Genetic Predisposition Factor for Secondary Myelofibrosis and Biomarker of Disease Severity. Leukemia. 2018. PMID: 29568096.

43. McCullough LL, Connell Z, Xin H, et al. Functional Roles of the DNA-Binding Hmgb Domain in the Histone Chaperone Fact in Nucleosome Reorganization. J Biol Chem. 2018. PMID: 29514976.

44. McDevitt S, Rusanov T, Kent T, Chandramouly G, Pomerantz RT. How Rna Transcripts Coordinate DNA Recombination and Repair. Nat Commun. 2018;9(1):1091. PMID: 29545568. PMC5854605.

45. Metcalfe MJ, Smaldone MC, Lin DW, Aparicio AM, Chapin BF. Role of Radical Prostatectomy in Metastatic Prostate Cancer: A Review. Urol Oncol. 2017;35(4):125-134. PMID: 28190749.

46. Mishra OP, Popov AV, Pietrofesa RA, Nakamaru-Ogiso E, Andrake M, Christofidou-Solomidou M. Synthetic Secoisolariciresinol Diglucoside (Lgm2605) Inhibits Myeloperoxidase Activity in Inflammatory Cells. Biochim Biophys Acta. 2018;1862(6):1364-1375. PMID: 29524540.

47. Morgans AK, Chen YH, Sweeney CJ, et al. Quality of Life During Treatment with Chemohormonal Therapy: Analysis of E3805 Chemohormonal Androgen Ablation Randomized Trial in Prostate Cancer. J Clin Oncol. 2018:Jco2017753335. PMID: 29522362.

48. Mortazavi S, Mortazavi S. Comment on ‘Cell Phone Use and Ill Health: Is There a Definite Relationship?’. South African Family Practice. 2018:1-2.

49. Mortazavi SMJ. Re: Revisiting the Alerting Effect of Light; a Systematic Review. Sleep Med Rev. 2018. PMID: 29519607.

50. Mortazavi SMJ, Doss M. Comments on “High Radon Areas and Lung Cancer Prevalence: Evidence from Ireland”. J Environ Radioact. 2018. PMID: 29602599.

51. Mortazavi SMJ, Mortazavi SAR, Paknahad M. Cancers of the Brain and Cns: Global Patterns and Trends in Incidence. Journal of Biomedical Physics and Engineering. 2018;8(1):I-II.

52. Motzer RJ, Tannir NM, McDermott DF, et al. Nivolumab Plus Ipilimumab Versus Sunitinib in Advanced Renal-Cell Carcinoma. N Engl J Med. 2018. PMID: 29562145.

53. Natarajaseenivasan K, Cotto B, Shanmughapriya S, et al. Astrocytic Metabolic Switch Is a Novel Etiology for Cocaine and Hiv-1 Tat-Mediated Neurotoxicity. Cell Death Dis. 2018;9(4):415. PMID: 29549313.

54. Owonikoko TK, Borghaei H. Immunotherapy of Lung Cancer. J Thorac Dis. 2018;10(Suppl 3):S395-s396. PMID: 29593884. PMC5861270.

55. Peng HZ, Prokop J, Karar J, et al. Familial and Somatic Bap1 Mutations Inactivate Asxl1/2-Mediated Allosteric Regulation of Bap1 Deubiquitinase by Targeting Multiple Independent Domains. Cancer Research. 2018;78(5):1200-1213.

56. Phipps AI, Shi Q, Zemla TJ, et al. Physical Activity and Outcomes in Patients with Stage Iii Colon Cancer: A Correlative Analysis of Phase Iii Trial Ncctg N0147 (Alliance). Cancer Epidemiol Biomarkers Prev. 2018. PMID: 29563133.

57. Pourfarhangi KE, Bergman A, Gligorijevic B. Ecm Cross-Linking Regulates Invadopodia Dynamics. Biophys J. 2018;114(6):1455-1466. PMID: 29590602.

58. Qumseya BJ, Bartel MJ, Gendy S, Bain P, Qumseya A, Wolfsen H. High Rate of over-Staging of Barrett’s Neoplasia with Endoscopic Ultrasound: Systemic Review and Meta-Analysis. Dig Liver Dis. 2018. PMID: 29573963.

59. Reese AC, Wessel SR, Fisher SG, Mydlo JH. Evidence of Prostate Cancer “Reverse Stage Migration” toward More Advanced Disease at Diagnosis: Data from the Pennsylvania Cancer Registry. Urol Oncol. 2016;34(8):335.e321-338. PMID: 27108226.

60. Riddle DL, Jensen MP, Ang D, Slover J, Perera R, Dumenci L. Do Pain Coping and Pain Beliefs Associate with Outcome Measures before Knee Arthroplasty in Patients Who Catastrophize About Pain? A Cross-Sectional Analysis from a Randomized Clinical Trial. Clin Orthop Relat Res. 2018;476(4):778-786. PMID: 29543659.

61. Ristau BT, Chen DYT, Ellis J, et al. Defining Novel and Practical Metrics to Assess the Deliverables of Multiparametric Magnetic Resonance Imaging/Ultrasound Fusion Prostate Biopsy. Journal of Urology. 2018;199(4):969-975.

62. Rose JJ, Del Monte J, Groman A, et al. Chemotherapy Extravasation Establishing a National Benchmark for Incidence among Cancer Centers. Clinical Journal of Oncology Nursing. 2017;21(4):438-445.

63. Ross KC, Chin KF, Kim D, Marion CD, Yen TJ, Bhattacharjee V. Methotrexate Sensitizes Drug-Resistant Metastatic Melanoma Cells to Braf V600e Inhibitors Dabrafenib and Encorafenib. Oncotarget. 2018;9(17):13324-13336. PMID: 29568360. PMC5862581
.
64. Sanku RKK, John JS, Salkovitz M, Ilies MA, Walker EA. Potential Learning and Memory Disruptors and Enhancers in a Simple, 1-Day Operant Task in Mice. Behav Pharmacol. 2018. PMID: 29570113.

65. Silva RS, Kido LA, Montico F, Vendramini-Costa DB, Pilli RA, Cagnon VHA. Steroidal Hormone and Morphological Responses in the Prostate Anterior Lobe in Different Cancer Grades after Celecoxib and Goniothalamin Treatments in Tramp Mice. Cell Biol Int. 2018. PMID: 29603508.

66. Siminoff LA, Gardiner HM, Wilson-Genderson M, Shafer TJ. How Inaccurate Metrics Hide the True Potential for Organ Donation in the United States. Prog Transplant. 2018;28(1):12-18. PMID: 29592635.

67. Siminoff LA, Wilson-Genderson M, Mosavel M, et al. Impact of Cognitive Load on Family Decision Makers’ Recall and Understanding of Donation Requests for the Genotype-Tissue Expression (Gtex) Project. J Clin Ethics. 2018;29(1):20-30. PMID: 29565794.

68. Steffen LE, Vowles KE, Smith BW, Gan GN, Edelman MJ. Daily Diary Study of Hope, Stigma, and Functioning in Lung Cancer Patients. Health Psychology. 2018;37(3):218-227.

69. Teixeira-Poit SM, Halpern MT, Kane HL, Keating M, Olmsted M. Factors Influencing Professional Life Satisfaction among Neurologists. BMC Health Serv Res. 2017;17(1):409. PMID: 28629403. PMC5477134.

70. Teye EK, Sido A, Xin P, et al. Pign Gene Expression Aberration Is Associated with Genomic Instability and Leukemic Progression in Acute Myeloid Leukemia with Myelodysplastic Features. Oncotarget. 2017;8(18):29887-29905. PMID: 28187452. PMC5444711.

71. Tripicchio GL, Ammerman AS, Ward DS, et al. Clinical-Community Collaboration: A Strategy to Improve Retention and Outcomes in Low-Income Minority Youth in Family-Based Obesity Treatment. Child Obes. 2018. PMID: 29584452.

72. von Massenhausen A, Tonnus W, Himmerkus N, et al. Phenytoin Inhibits Necroptosis. Cell Death Dis. 2018;9(3):359. PMID: 29500402. PMC5834524.

73. Vyfhuis MAL, Burrows WM, Bhooshan N, et al. Implications of Pathologic Complete Response Beyond Mediastinal Nodal Clearance with High-Dose Neoadjuvant Chemoradiation Therapy in Locally Advanced, Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2018. PMID: 29559292.

74. Weinberg DS, Pickhardt PJ, Bruining DH, et al. Computed Tomography Colonography Vs Colonoscopy for Colorectal Cancer Surveillance after Surgery. Gastroenterology. 2018;154(4):927-+.

75. Winer A, Bodor JN, Borghaei H. Identifying and Managing the Adverse Effects of Immune Checkpoint Blockade. J Thorac Dis. 2018;10(Suppl 3):S480-s489. PMID: 29593893. PMC5861268.

76. Yadav RK, Jablonowski CM, Fernandez AG, et al. Histone H3g34r Mutation Causes Replication Stress, Homologous Recombination Defects and Genomic Instability in S. Pombe. Elife. 2017;6. PMID: 28718400. PMC5515577.

77. Zendejas B, Jakub JW, Terando AM, et al. Laparoscopic Skill Assessment of Practicing Surgeons Prior to Enrollment in a Surgical Trial of a New Laparoscopic Procedure. Surg Endosc. 2017;31(8):3313-3319. PMID: 27928664.

78. Zhang Z, Remsing RC, Chakraborty H, et al. Light-Induced Dilation in Nanosheets of Charge-Transfer Complexes. Proc Natl Acad Sci U S A. 2018. PMID: 29581284.

79. Zibelman M, Plimack ER. Immunotherapy for Metastatic Urothelial Carcinoma: Putting the Brakes on Releasing the Brake. Immunotherapy. 2018;10(6):423-425. PMID: 29562856.

80. Zou ZW, Liu T, Li Y, et al. Melatonin Suppresses Thyroid Cancer Growth and Overcomes Radioresistance Via Inhibition of P65 Phosphorylation and Induction of Ros. Redox Biol. 2018;16:226-236. PMID: 29525603. PMC5854931.

81. Zou ZW, Ma C, Medoro L, et al. Lncrna Anril Is up-Regulated in Nasopharyngeal Carcinoma and Promotes the Cancer Progression Via Increasing Proliferation, Reprograming Cell Glucose Metabolism and Inducing Side-Population Stem-Like Cancer Cells. Oncotarget. 2016;7(38):61741-61754. PMID: 27557514. PMC5308687.

82. Zuniga SA, Ebersole B, Jamal N. Utility of Eating Assessment Tool-10 in Predicting Aspiration in Patients with Unilateral Vocal Fold Paralysis. Otolaryngol Head Neck Surg. 2018:194599818762328. PMID: 29529920.

Staff Publications: February 2018

1. Abbas AM, Strong AT, Diehl DL, et al. Multicenter Evaluation of the Clinical Utility of Laparoscopy-Assisted Ercp in Patients with Roux-En-Y Gastric Bypass. Gastrointestinal Endoscopy. 2018.

2. Abbosh PH, Plimack ER. Molecular and Clinical Insights into the Role and Significance of Mutated DNA Repair Genes in Bladder Cancer. Bladder Cancer. 2018;4(1):9-18. PMID: 29430503. PMC5798524.

3. Adamsky MA, Boysen WR, Cohen AJ, et al. Evaluating the Role of Postoperative Oral Antibiotic Administration in Artificial Urinary Sphincter and Inflatable Penile Prosthesis Explantation: A Nationwide Analysis. Urology. 2018;111:92-98.

4. Al-Kawas F, Aslanian H, Baillie J, et al. Percutaneous Transhepatic Vs. Endoscopic Retrograde Biliary Drainage for Suspected Malignant Hilar Obstruction: Study Protocol for a Randomized Controlled Trial. Trials. 2018;19(1):108. PMID: 29444707. PMC5813390.

5. Araiza-Olivera D, Feng Y, Semenova G, Prudnikova TY, Rhodes J, Chernoff J. Suppression of Rac1-Driven Malignant Melanoma by Group a Pak Inhibitors. Oncogene. 2018;37(7):944-952.

6. Atkins MB, Plimack ER, Puzanov I, et al. Axitinib in Combination with Pembrolizumab in Patients with Advanced Renal Cell Cancer: A Non-Randomised, Open-Label, Dose-Finding, and Dose-Expansion Phase 1b Trial. Lancet Oncol. 2018. PMID: 29439857.

7. Bagrodia A, Woldu S, Penson DF, Kutikov A, Kaffenberger SD. Re: Sophia C. Kamran, Thomas Seisen, Sarah C. Markt, Et Al. Contemporary Treatment Patterns and Outcomes for Clinical Stage Is Testicular Cancer. Eur Urol. In Press. Http://Dx.Doi.Org/10.1016/J.Eururo.2017.06.013. Eur Urol. 2017.

8. Barr PM, Li H, Burack WR, et al. R-Chop, Radioimmunotherapy, and Maintenance Rituximab in Untreated Follicular Lymphoma (Swog S0801): A Single-Arm, Phase 2, Multicentre Study. Lancet Haematol. 2018. PMID: 29396094.

9. Bartel MJ, Puri R, Brahmbhatt B, et al. Correction To: Endoscopic and Surgical Management of Nonampullary Duodenal Neoplasms. Surg Endosc. 2018. PMID: 29468272.

10. Bartel MJ, Puri R, Brahmbhatt B, et al. Endoscopic and Surgical Management of Nonampullary Duodenal Neoplasms. Surg Endosc. 2018. PMID: 29392469.

11. Bradbury AR, Patrick-Miller LJ, Egleston BL, et al. Randomized Noninferiority Trial of Telephone Vs in-Person Disclosure of Germline Cancer Genetic Test Results. J Natl Cancer Inst. 2018. PMID: 29490071.

12. Cagney DN, Martin AM, Catalano PJ, et al. Impact of Pemetrexed on Intracranial Disease Control and Radiation Necrosis in Patients with Brain Metastases from Non-Small Cell Lung Cancer Receiving Stereotactic Radiation. Radiother Oncol. 2018. PMID: 29398153.

13. Carqueijeiro I, Duge de Bernonville T, Lanoue A, et al. A Bahd Acyltransferase Catalyzing 19-O-Acetylation of Tabersonine Derivatives in Roots of Catharanthus Roseus Enables Combinatorial Synthesis of Monoterpene Indole Alkaloids. Plant J. 2018. PMID: 29438577.

14. Cheng D, Zhao S, Tang H, et al. Microrna-20a-5p Promotes Colorectal Cancer Invasion and Metastasis by Downregulating Smad4. Oncotarget. 2016;7(29):45199-45213. PMID: 27286257. PMC5216716.

15. Churilla TM, DeMora L, Handorf E, et al. Deviations from Standard Chemoradiation among Early-Stage Anal Cancer Patients. Int J Radiat Oncol Biol Phys. 2018;100(4):945-949. PMID: 29485073.

16. Czyz M, Toma M, Gajos-Michniewicz A, et al. Parp1 Inhibitor Olaparib (Lynparza) Exerts Synthetic Lethal Effect against Ligase 4-Deficient Melanomas. Oncotarget. 2016;7(46):75551-75560. PMID: 27705909. PMC5342760.

17. Doss M. Comment on ’30 Years Follow-up and Increased Risks of Breast Cancer and Leukaemia after Long-Term Low-Dose-Rate Radiation Exposure’. Br J Cancer. 2018. PMID: 29438374.
18. Drilon A, Laetsch TW, Kummar S, et al. Efficacy of Larotrectinib in Trk Fusion-Positive Cancers in Adults and Children. N Engl J Med. 2018;378(8):731-739. PMID: 29466156.

19. Egleston BL, Pedraza O, Wong YN, Griffin CL, Ross EA, Beck JR. Temporal Trends and Characteristics of Clinical Trials for Which Only One Racial or Ethnic Group Is Eligible. Contemporary Clinical Trials Communications. 2018;9:135-142.

20. Elliott B, Zackery DL, Eaton VA, et al. Ethnic Differences in Tgfbeta Signaling Pathway May Contribute to Prostate Cancer Health Disparity. Carcinogenesis. 2018. PMID: 29474521.

21. Erkmen CP, Moore RF, Belden C, et al. Overcoming Barriers to Lung Cancer Screening by Implementing a Single-Visit Patient Experience. Int J Cancer Oncol. 2017;4(2). PMID: 29399636. PMC5796669. NIHMS888832.

22. Escudier B, Sharma P, McDermott DF, et al. Erratum to “Checkmate 025 Randomized Phase 3 Study: Outcomes by Key Baseline Factors and Prior Therapy for Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma” [Eur Urol 2017;72:962-71]. Eur Urol. 2018.

23. Fahl SP, Coffey F, Kain L, et al. Role of a Selecting Ligand in Shaping the Murine Gammadelta-Tcr Repertoire. Proc Natl Acad Sci U S A. 2018;115(8):1889-1894. PMID: 29432160.

24. Fang CY, Tseng M. Ethnic Density and Cancer: A Review of the Evidence. Cancer. 2018. PMID: 29411868.

25. Frankel AS, Bass SB, Patterson F, Dai T, Brown D. Sexting, Risk Behavior, and Mental Health in Adolescents: An Examination of 2015 Pennsylvania Youth Risk Behavior Survey Data. J Sch Health. 2018;88(3):190-199. PMID: 29399839.

26. Fundakowski CE, Hales NW, Agarwal N, et al. Surgical Management of the Recurrent Laryngeal Nerve in Thyroidectomy: American Head and Neck Society Consensus Statement. Head Neck. 2018. PMID: 29461666.

27. Gerhard GS, Fisher SG, Feldman AM. Genetic Testing for Inherited Cardiac Diseases in Underserved Populations of Non-European Ancestry: Double Disparity. JAMA Cardiol. 2018. PMID: 29490336.

28. Giri VN, Knudsen KE, Kelly WK, et al. Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017. Journal of Clinical Oncology. 2018;36(4):414-424.

29. Godwin JL, Hoffman-Censits J, Plimack E. Recent Developments in the Treatment of Advanced Bladder Cancer. Urol Oncol. 2018. PMID: 29395952.

30. Goetz A, Nweze N, Joshi A, Farma J. Synchronous Subcutaneous Granular Cell Tumours, a Rare Presentation. Ann R Coll Surg Engl. 2018:e1-e3. PMID: 29484942.

31. Gordon RE, Zhang L, Peri S, et al. Statins Synergize with Hedgehog Pathway Inhibitors for Treatment of Medulloblastoma. Clin Cancer Res. 2018. PMID: 29437795.

32. Haifler M, Pence I, Sun Y, et al. Discrimination of Malignant and Normal Kidney Tissue with Short Wave Infra-Red Dispersive Raman Spectroscopy. J Biophotonics. 2018. PMID: 29411949.

33. Handorf EA, Heitjan DF, Bekelman JE, Mitra N. Estimating Cost-Effectiveness from Claims and Registry Data with Measured and Unmeasured Confounders. Stat Methods Med Res. 2018:962280218759137. PMID: 29468944.

34. Handra-Luca A, Wei S. Intrathyroid Cystic Thyroglossal Duct Remnant and Ectopic Thymus: A Fortuitous or Development-Related Association? Surg Today. 2018. PMID: 29460127.

35. Harshman LC, Chen YH, Liu G, et al. Seven-Month Prostate-Specific Antigen Is Prognostic in Metastatic Hormone-Sensitive Prostate Cancer Treated with Androgen Deprivation with or without Docetaxel. Journal of Clinical Oncology. 2018;36(4):376-382.

36. Hernandez-Borrero LJ, Zhang S, Lulla A, Dicker DT, El-Deiry WS. Cb002, a Novel P53 Tumor Suppressor Pathway-Restoring Small Molecule Induces Tumor Cell Death through the Pro-Apoptotic Protein Noxa. Cell Cycle. 2018:1-11.

37. Horwitz SM, Ansell SM, Ai WZ, et al. T-Cell Lymphomas, Version 2.2018 Featured Updates to the Nccn Guidelines. JNCCN Journal of the National Comprehensive Cancer Network. 2018;16(2):123-135.

38. Jain R, Dotan E. Nutrition and Aging: A Practicing Oncologist’s Perspective. Current Oncology Reports. 2017;19(11).

39. Kamboj M, Brite J, Aslam A, et al. Artificial Differences in Clostridium Difficile Infection Rates Associated with Disparity in Testing. Emerging Infectious Diseases. 2018;24(3):584-587.

40. Karlova MG, Volokh OI, Chertkov OV, Kirpichnikov MP, Studitsky VM, Sokolova OS. Purification and Concentration of Rna Polymerase on Ni-Lipid Monolayers. Russian Journal of Bioorganic Chemistry. 2017;43(6):658-663.

41. Kasimova MA, Yazici A, Yudin Y, et al. Ion Channel Sensing: Are Fluctuations the Crux of the Matter? J Phys Chem Lett. 2018:1260-1264. PMID: 29439562.

42. Katsnelson M, Hwang WT, Tahirovic E, Rubin SC, Tanyi JL. Preoperative Predictors That Impact the Survival and Outcome of Patients Undergoing Secondary Cytoreduction for Ovarian Cancer. J Obstet Gynaecol. 2018:1-7. PMID: 29385863.

43. Kishan AU, Shaikh T, Wang PC, et al. Clinical Outcomes for Patients with Gleason Score 9-10 Prostate Adenocarcinoma Treated with Radiotherapy or Radical Prostatectomy: A Multi-Institutional Comparative Analysis. Eur Urol. 2017;71(5):766-773. PMID: 27452951.

44. Koch C, Schwing AM, Herrmann E, et al. Bevacizumab-Based First-Line Chemotherapy in Elderly Patients with Metastatic Colorectal Cancer: An Individual Patient Data Based Meta-Analysis. Oncotarget. 2018;9(12):10272-10283.

45. Koh WJ, Abu-Rustum NR, Bean S, et al. Uterine Neoplasms, Version 1.2018 Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network. 2018;16(2):170-199.

46. Lee CT, Dong Y, Li T, et al. Local Control and Toxicity of External Beam Reirradiation with a Pulsed Low-Dose-Rate Technique. Int J Radiat Oncol Biol Phys. 2018;100(4):959-964. PMID: 29485075.

47. Localio AR, Goodman SN, Meibohm A, et al. Statistical Code to Support the Scientific Story. Ann Intern Med. 2018. PMID: 29404564.

48. Lounsbury N, Eidem T, Colquhoun J, et al. Novel Inhibitors of Staphylococcus Aureus Rnpa That Synergize with Mupirocin. Bioorg Med Chem Lett. 2018. PMID: 29463447.

49. Majtan T, Jones W, Jr., Krijt J, et al. Enzyme Replacement Therapy Ameliorates Multiple Symptoms of Murine Homocystinuria. Mol Ther. 2017. PMID: 29398487.

50. Marty R, de Prisco N, Carter H, Font-Burgada J. Mhc-I Genotype Drives Early Immune Selection of Oncogenic Mutations. Mol Cell Oncol. 2018;5(2):e1409863. PMID: 29487895. PMC5821412.

51. Matthew EM, Yang Z, Peri S, et al. Plk2 Loss Commonly Occurs in Colorectal Carcinomas but Not Adenomas: Relationship to Mtor Signaling. Neoplasia. 2018;20(3):244-255. PMID: 29448085.

52. Mehren MV, Joensuu H. Gastrointestinal Stromal Tumors. Journal of Clinical Oncology. 2018;36(2):136-143.

53. Messina NM, Rossi K, Wetherhold LM, et al. Optimizing Donor Site Closure Following Bilateral Breast Reconstruction with Abdominal-Based Free Flaps. Journal of Plastic Reconstructive and Aesthetic Surgery. 2018;71(2):269-271.

54. Mortazavi SAR, Mortazavi SMJ. Women with Hereditary Breast Cancer Predispositions Should Avoid Using Their Smartphones, Tablets, and Laptops at Night. Iran J Basic Med Sci. 2018;21(2):112-115. PMID: 29456806. PMC5811748.

55. Mortazavi SMJ. Cell Phones, Cancer, and Other Problems. Physics Teacher. 2018;56(3):131.

56. Mortazavi SMJ. Comments on “Physician Knowledge of Radiation Exposure and Risk in Medical Imaging”. J Am Coll Radiol. 2018. PMID: 29398502.

57. Mortazavi SMJ. Comments on “Sesamol Ameliorates Radiation Induced DNA Damage in Hematopoietic System of Whole Body -Irradiated Mice”. Environmental and Molecular Mutagenesis. 2018;59(2):170-171.

58. Mortazavi SMJ. Comments on “Sesamol Ameliorates Radiation Induced DNA Damage in Hematopoietic System of Whole Body Γ-Irradiated Mice”. Environmental and Molecular Mutagenesis. 2018;59(2):170-171.

59. Mortazavi SMJ, Bevelacqua JJ, Fornalski KW, et al. Letter to the Editor (August 24, 2017) Concerning the Paper “Occupational Exposure to Radon for Underground Tourist Routes in Poland: Doses to Lung and the Risk of Developing Lung Cancer”. Int J Occup Med Environ Health. 2018. PMID: 29416140.

60. Mortazavi SMJ, Mortazavi G. Re: Blood Mercury Concentration in Relation to Metabolic and Weight Phenotypes Using the Knhanes 2011-2013 Data. International Archives of Occupational and Environmental Health. 2018;91(2):247-247.

61. Moten AS, Movva S, von Mehren M, et al. Granular Cell Tumor Experience at a Comprehensive Cancer Center. Journal of Surgical Research. 2018;226:1-7.

62. Naaman H, Rabinski T, Yizhak A, et al. Measles Virus Persistent Infection of Human Induced Pluripotent Stem Cells. Cell Reprogram. 2018;20(1):17-26. PMID: 29412740. PMC5804099.

63. Nikonova AS, Deneka AY, Kiseleva AA, et al. Ganetespib Limits Ciliation and Cystogenesis in Autosomal-Dominant Polycystic Kidney Disease (Adpkd). Faseb j. 2018:fj201700909R. PMID: 29401581.

64. Norquist BM, Brady MF, Harrell MI, et al. Mutations in Homologous Recombination Genes and Outcomes in Ovarian Carcinoma Patients in Gog 218: An Nrg Oncology/Gynecologic Oncology Group Study. Clinical Cancer Research. 2018;24(4):777-783.

65. Overman MJ, Morris V, Moinova H, et al. Phase I/Ii Study of Azacitidine and Capecitabine/Oxaliplatin (Capox) in Refractory Cimp-High Metastatic Colorectal Cancer: Evaluation of Circulating Methylated Vimentin. Oncotarget. 2016;7(41):67495-67506. PMID: 27542211. PMC5341892.

66. Ozdemir AY, Rusanov T, Kent T, Siddique LA, Pomerantz RT. Polymerase Theta-Helicase Efficiently Unwinds DNA and Rna-DNA Hybrids. J Biol Chem. 2018. PMID: 29444826.

67. Podszywalow-Bartnicka P, Cmoch A, Wolczyk M, et al. Increased Phosphorylation of Eif2alpha in Chronic Myeloid Leukemia Cells Stimulates Secretion of Matrix Modifying Enzymes. Oncotarget. 2016;7(48):79706-79721. PMID: 27802179. PMC5346746.

68. Prabhu VV, Talekar MK, Lulla AR, et al. Single Agent and Synergistic Combinatorial Efficacy of First-in-Class Small Molecule Imipridone Onc201 in Hematological Malignancies. Cell Cycle. 2018:1-11.

69. Randhawa S, Moore RF, DiSesa V, et al. Role of Thoracic Surgeons in Lung Cancer Screening: Opportune Time for Involvement. J Thorac Oncol. 2018;13(3):298-300. PMID: 29472053.

70. Riddle DL, Ghomrawi H, Jiranek WA, Dumenci L, Perera RA, Escobar A. Appropriateness Criteria for Total Knee Arthroplasty: Additional Comments and Considerations. J Bone Joint Surg Am. 2018;100(4):e22. PMID: 29462044.

71. Ristau BT, Kutikov A. Natural History of Complex Renal Cysts: Clinical Evidence Supporting Active Surveillance Editorial Comments. Journal of Urology. 2018;199(3):639-640.

72. Sartor O, Vogelzang NJ, Sweeney C, et al. Radium-223 Safety, Efficacy, and Concurrent Use with Abiraterone or Enzalutamide: First US Experience from an Expanded Access Program. Oncologist. 2018;23(2):193-202.

73. Schmier J, Ogden K, Nickman N, et al. Costs of Providing Infusion Therapy for Rheumatoid Arthritis in a Hospital-Based Infusion Center Setting. Clin Ther. 2017;39(8):1600-1617. PMID: 28716293.

74. Schootman M, Gomez SL, Henry KA, et al. Geospatial Approaches to Cancer Control and Population Sciences. Cancer Epidemiol Biomarkers Prev. 2017;26(4):472-475. PMID: 28325736. PMC5380532. NIHMS853745.

75. Seeger C. Control of Viral Transcripts as a Concept for Future Hbv Therapies. Curr Opin Virol. 2018;30:18-23. PMID: 29453098.

76. Seliga A, Lee MH, Fernandes NC, et al. Kallikrein-Kinin System Suppresses Type I Interferon Responses: A Novel Pathway of Interferon Regulation. Front Immunol. 2018;9:156. PMID: 29456540. PMC5801412.

77. Shaikh T, Handorf EA, Meyer JE, Hall MJ, Esnaola NF. Mismatch Repair Deficiency Testing in Patients with Colorectal Cancer and Nonadherence to Testing Guidelines in Young Adults. JAMA Oncology. 2018;4(2).

78. Soboloff J, Gligorijevic B, Zaidi MR. Stim1 (C)Amps up Melanogenesis. Embo j. 2018. PMID: 29449324.

79. Toland AE, Forman A, Couch FJ, et al. Clinical Testing of Brca1 and Brca2: A Worldwide Snapshot of Technological Practices. npj Genomic Medicine. 2018;3(1).

80. Toma M, Skorski T, Sliwinski T. DNA Double Strand Break Repair – Related Synthetic Lethality. Curr Med Chem. 2018. PMID: 29421999.

81. Westerberg BD, Lango MN. Otolaryngology-Related Disorders in Underserved Populations, Otolaryngology Training and Workforce Considerations in North America. Otolaryngol Clin North Am. 2018. PMID: 29482920.

82. Winer A, Nicholas Bodor J, Borghaei H. Identifying and Managing the Adverse Effects of Immune Checkpoint Blockade. Journal of Thoracic Disease. 2018;10:S480-S489.

83. Wu HC, Do C, Andrulis IL, et al. Breast Cancer Family History and Allele-Specific DNA Methylation in the Legacy Girls Study. Epigenetics. 2018:1-23. PMID: 29436922.

84. Xiao X, Putatunda R, Zhang Y, et al. Lymphotoxin Beta Receptor-Mediated Nfkappab Signaling Promotes Glial Lineage Differentiation and Inhibits Neuronal Lineage Differentiation in Mouse Brain Neural Stem/Progenitor Cells. J Neuroinflammation. 2018;15(1):49. PMID: 29463313. PMC5819232.

85. Xu K, Yang WY, Nanayakkara GK, et al. Gata3, Hdac6, and Bcl6 Regulate Foxp3+ Treg Plasticity and Determine Treg Conversion into Either Novel Antigen-Presenting Cell-Like Treg or Th1-Treg. Front Immunol. 2018;9:45. PMID: 29434588. PMC5790774.

86. Yamazaki J, Jelinek J, Hisamoto S, Tsukamoto A, Inaba M. Dynamic Changes in DNA Methylation Patterns in Canine Lymphoma Cell Lines Demonstrated by Genome-Wide Quantitative DNA Methylation Analysis. Vet J. 2018;231:48-54. PMID: 29429487.

87. Yu JQ, Doss M, Alpaugh RK. Normal Variants and Pitfalls Encountered in Pet Assessment of Gynecologic Malignancies. PET Clin. 2018;13(2):249-268. PMID: 29482753.

Staff Publications: January 2018

1. Alberro JA, Ballester B, Deulofeu P, et al. Long-Term Outcomes for Neoadjuvant Versus Adjuvant Chemotherapy in Early Breast Cancer: Meta-Analysis of Individual Patient Data from Ten Randomised Trials. Lancet Oncology. 2018;19(1):27-39.

2. Bai T, Chanda AK, Egleston BL, Vucetic S. Joint Learning of Representations of Medical Concepts and Words from Ehr Data. Proceedings (IEEE Int Conf Bioinformatics Biomed). 2017;2017:764-769. PMID: 29375929. PMC5783648. NIHMS928144.

3. Balasubramanian S, Rajagopalan M, Bojja RS, Skalka AM, Andrake MD, Ramaswamy A. The Conformational Feasibility for the Formation of Reaching Dimer in ASV and HIV Integrase: A Molecular Dynamics Study. Journal of Biomolecular Structure & Dynamics. 2017;35(16):3469-3485.

4. Bevelacqua JJ, Mortazavi SMJ. Commentary: Human Pathophysiological Adaptations to the Space Environment. Front Physiol. 2017;8:1116. PMID: 29358922. PMC5766677.

5. Brigle K, Rogers B. Pathobiology and Diagnosis of Multiple Myeloma. Seminars in Oncology Nursing. 2017;33(3):225-236.

6. Bryant KG, Chae YC, Martinez RL, et al. A Mitochondrial-Targeted Purine-Based Hsp90 Antagonist for Leukemia Therapy. Oncotarget. 2017;8(68):112184-112198. PMID: 29348817. PMC5762502.

7. Coccia PF, Pappo AS, Beaupin L, et al. Adolescent and Young Adult Oncology, Version 2.2018. Journal of the National Comprehensive Cancer Network. 2018;16(1):66-97.

8. Crawford J, Becker PS, Armitage JO, et al. Myeloid Growth Factors, Version 2.2017. JNCCN Journal of the National Comprehensive Cancer Network. 2017;15(12):1520-1541.

9. Demark-Wahnefried W, Schmitz KH, Alfano CM, et al. Weight Management and Physical Activity Throughout the Cancer Care Continuum. CA Cancer Journal for Clinicians. 2018;68(1):64-89.

10. Ebersole B, Soni RS, Moran K, Lango M, Devarajan K, Jamal N. The Influence of Occupation on Self-Perceived Vocal Problems in Patients with Voice Complaints. Journal of Voice. 2017.

11. Fareed MM, Eldib AA, Weiss SE, Hayes SB, Li J, Ma CC. A Treatment Planning Comparison between a Novel Rotating Gamma System and Robotic Linear Accelerator Based Intracranial Stereotactic Radiosurgery/Radiotherapy. Phys Med Biol. 2018. PMID: 29300187.

12. Galal Osman A, Elokely KM, Yadav VK, et al. Bioactive Products from Singlet Oxygen Photooxygenation of Cannabinoids. Eur J Med Chem. 2018;143:983-996. PMID: 29232588.

13. Galluzzi L, Vitale I, Aaronson SA, et al. Molecular Mechanisms of Cell Death: Recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ. 2018. PMID: 29362479.

14. Geynisman DM, Abbosh PH, Plimack ER, Zibelman M. Chemoimmunotherapy in Metastatic Urothelial Carcinoma. Eur Urol. 2018. PMID: 29331216.

15. Ghatalia P, Pond GR, Templeton AJ, Sonpavde G. Effect of Single-Agent Daily Prednisone on Outcomes and Toxicities in Metastatic Castration-Resistant Prostate Cancer: Pooled Analysis of Prospective Studies. Clin Genitourin Cancer. 2017. PMID: 29352714.

16. Graves KD, Hall MJ, Tercyak KP. Introduction to the Special Issue on Clinical and Public Health Genomics: Opportunities for Translational Behavioral Medicine Research, Practice, and Policy. Transl Behav Med. 2018;8(1):4-6. PMID: 29385593.

17. Gray HJ, Bell-McGuinn K, Fleming GF, et al. Phase I Combination Study of the Parp Inhibitor Veliparib Plus Carboplatin and Gemcitabine in Patients with Advanced Ovarian Cancer and Other Solid Malignancies. Gynecol Oncol. 2018. PMID: 29352572.

18. Haifler M, Ristau BT, Higgins AM, et al. External Validation of Contact Surface Area as a Predictor of Postoperative Renal Function in Patients Undergoing Partial Nephrectomy. Journal of Urology. 2018.

19. Haldane A, Flynn WF, He P, Levy RM. Coevolutionary Landscape of Kinase Family Proteins: Sequence Probabilities and Functional Motifs. Biophys J. 2018;114(1):21-31. PMID: 29320688.

20. Han H, Pan M, Tao Y, et al. Early Enteral Nutrition Is Associated with Faster Post-Esophagectomy Recovery in Chinese Esophageal Cancer Patients: A Retrospective Cohort Study. Nutr Cancer. 2018:1-8. PMID: 29313724.

21. Hsieh FK, Kozlova AL, Gerasimova NS, Kotova EY, Formosa T, Studitsky VM. Role of the Nhp6 Protein in in Vitro Transcription through the Nucleosome. Moscow University Biological Sciences Bulletin. 2017;72(4):218-221.

22. Huang X, Qin X, Yang W, et al. Mthfr Gene and Serum Folate Interaction on Serum Homocysteine Lowering: Prospect for Precision Folic Acid Treatment. Arterioscler Thromb Vasc Biol. 2018. PMID: 29371246.

23. Jackson WC, Dess RT, Litzenberg DW, et al. A Multi-Institutional Phase 2 Trial of Prostate Stereotactic Body Radiation Therapy (Sbrt) Using Continuous Real-Time Evaluation of Prostate Motion with Patient-Reported Quality of Life. Pract Radiat Oncol. 2018;8(1):40-47. PMID: 29304991.

24. Jung K, Ghatalia P, Litwin S, et al. Small-Cell Carcinoma of the Bladder: 20-Year Single-Institution Retrospective Review. Clin Genitourin Cancer. 2017;15(3):E337-E343.

25. Kayser K, Acquati C, Reese JB, Mark K, Wittmann D, Karam E. A Systematic Review of Dyadic Studies Examining Relationship Quality in Couples Facing Colorectal Cancer Together. Psycho-Oncology. 2018;27(1):13-21.

26. Keohane CE, Steele AD, Fetzer C, et al. Promysalin Elicits Species-Selective Inhibition of Pseudomonas Aeruginosa by Targeting Succinate Dehydrogenase. J Am Chem Soc. 2018. PMID: 29300464.

27. Kumar SK, Callander NS, Alsina M, et al. Nccn Guidelines Insights: Multiple Myeloma, Version 3.2018. J Natl Compr Canc Netw. 2018;16(1):11-20. PMID: 29295877.

28. Kyriakopoulos CE, Chen YH, Carducci MA, et al. Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase Iii E3805 Chaarted Trial. J Clin Oncol. 2018:Jco2017753657. PMID: 29384722.

29. Lee HO, Wang L, Kuo YM, Andrews AJ, Gupta S, Kruger WD. S-Adenosylhomocysteine Hydrolase over-Expression Does Not Alter S-Adenosylmethionine or S-Adenosylhomocysteine Levels in Cbs Deficient Mice. Molecular Genetics and Metabolism Reports. 2018;15:15-21.

30. Li P, Wong YN, Jahnke J, Pettit AR, Doshi JA. Association of High Cost Sharing and Targeted Therapy Initiation among Elderly Medicare Patients with Metastatic Renal Cell Carcinoma. Cancer Medicine. 2018;7(1):75-86.

31. Li PD, Chen P, Peng X, Ma C, Zhang WJ, Dai XF. Hoxc6 Predicts Invasion and Poor Survival in Hepatocellular Carcinoma by Driving Epithelial-Mesenchymal Transition. Aging (Albany NY). 2018. PMID: 29348394.

32. Li X, Shao Y, Sha X, et al. Il-35 (Interleukin-35) Suppresses Endothelial Cell Activation by Inhibiting Mitochondrial Reactive Oxygen Species-Mediated Site-Specific Acetylation of H3k14 (Histone 3 Lysine 14). Arterioscler Thromb Vasc Biol. 2018. PMID: 29371247.

33. Lyubitelev AV, Studitsky VM, Feofanov AV, Kirpichnikov MP. Effect of Sodium and Potassium Ions on Conformation of Linker Parts of Nucleosomes. Moscow University Biological Sciences Bulletin. 2017;72(3):146-150.

34. Maifrede S, Martinez E, Nieborowska-Skorska M, et al. Mll-Af9 Leukemias Are Sensitive to Parp1 Inhibitors Combined with Cytotoxic Drugs. Blood Adv. 2017;1(19):1467-1472. PMID: 29296788. PMC5728460.

35. Mikropoulos C, Selkirk CGH, Saya S, et al. Prostate-Specific Antigen Velocity in a Prospective Prostate Cancer Screening Study of Men with Genetic Predisposition. Br J Cancer. 2018;118(2):266-276. PMID: 29301143.

36. Mortazavi SM. Comment on “Mobile Phone Radiofrequency Exposure Has No Effect on DNA Double Strand Breaks (Dsb) in Human Lymphocytes”. Annals of Translational Medicine. 2017;5(21).

37. Mortazavi SMJ. Re: Are Electromagnetic Fields in Incubators a Risk Factor for Autism? Acta Paediatrica, International Journal of Paediatrics. 2017;106(12):2063.

38. Mortazavi SMJ, Bevelacqua JJ, Fornalski KW, Welsh J, Doss M. Comments on “Space: The Final Frontier-Research Relevant to Mars”. Health Phys. 2018;114(3):344-345. PMID: 29360711. PMC5784783. NIHMS920226.

39. Myers VD, Tomar D, Madesh M, et al. Haplo-Insufficiency of Bcl2-Associated Athanogene 3 in Mice Results in Progressive Left Ventricular Dysfunction, Beta-Adrenergic Insensitivity and Increased Apoptosis. J Cell Physiol. 2018. PMID: 29323723.

40. O’Malley D, Dewan AA, Ohman-Strickland PA, Gundersen DA, Miller SM, Hudson SV. Determinants of Patient Activation in a Community Sample of Breast and Prostate Cancer Survivors. Psycho-Oncology. 2018;27(1):132-140.

41. Packel L, Fang CY, Handorf E, Rodoletz M. A 12-Week Exercise and Stress Management Pilot Program from Theory through Implementation and Assessment. Rehabilitation Oncology. 2017;35(4):172-180.

42. Petrov R, Bakhos C, Abbas AE. Management of Malignant Lung Entrapment, the Oncothorax. Thoracic Surgery Clinics. 2018;28(1):81-+.

43. Reyngold M, Niland J, ter Veer A, et al. Trends in Intensity Modulated Radiation Therapy Use for Locally Advanced Rectal Cancer at National Comprehensive Cancer Network Centers. Advances in Radiation Oncology. 2018.

44. Ristau BT, Kutikov A. Editorial Comment. Journal of Urology. 2018.

45. Roboz GJ, Kantarjian HM, Yee KWL, et al. Dose, Schedule, Safety, and Efficacy of Guadecitabine in Relapsed or Refractory Acute Myeloid Leukemia. Cancer. 2018;124(2):325-334.

46. Sariyer R, De-Simone FI, Gordon J, Sariyer IK. Immune Suppression of Jc Virus Gene Expression Is Mediated by Srsf1. J Neurovirol. 2016;22(5):597-606. PMID: 26951564. PMC5014737. NIHMS766632.

47. Shadman M, Li H, Rimsza L, et al. Continued Excellent Outcomes in Previously Untreated Patients with Follicular Lymphoma after Treatment with Chop Plus Rituximab or Chop Plus (131)I-Tositumomab: Long-Term Follow-up of Phase Iii Randomized Study Swog-S0016. J Clin Oncol. 2018:Jco2017745083. PMID: 29356608.

48. Tagai EK, Miller SM, Kutikov A, et al. Prostate Cancer Patients’ Understanding of the Gleason Scoring System: Implications for Shared Decision-Making. J Cancer Educ. 2018. PMID: 29333577.

49. Tong C, Simhan J. Delayed Reconstruction of Bulbar Urethral Strictures Is Associated with Multiple Interventions, Longer Strictures and More Complex Repairs Editorial Comment. Journal of Urology. 2018;199(2):521-521.

50. von Mehren M, Joensuu H. Gastrointestinal Stromal Tumors. Journal of Clinical Oncology. 2018;36(2):136-+.

51. Wagner J, Kline CL, Zhou L, Khazak V, El-Deiry WS. Anti-Tumor Effects of Onc201 in Combination with Vegf-Inhibitors Significantly Impacts Colorectal Cancer Growth and Survival in Vivo through Complementary Non-Overlapping Mechanisms. J Exp Clin Cancer Res. 2018;37(1):11. PMID: 29357916.

52. Wahab A, Kesari K, S JS, Liu Y, Barta SK. Type B Lactic Acidosis, an Uncommon Paraneoplastic Syndrome. Cancer Biol Ther. 2018;19(2):101-104. PMID: 29293400.

53. Wang Y, Tian H, Cai W, et al. Tracking Hematopoietic Precursor Division Ex Vivo in Real Time. Stem Cell Res Ther. 2018;9(1):16. PMID: 29361987.

54. Ward WH, Manstein SM, Goel N, et al. Optimal Preoperative Assessment of the Geriatric Patient. Perioperative Care and Operating Room Management. 2017;9:33-38.

55. Ward WH, Sigurdson ER, Esposito AC, et al. Pathologic Response Following Treatment for Locally Advanced Rectal Cancer: Does Location Matter? Journal of Surgical Research. 2018;224:215-221.

56. Xiao Q, Ludwig AK, Romano C, et al. Exploring Functional Pairing between Surface Glycoconjugates and Human Galectins Using Programmable Glycodendrimersomes. Proc Natl Acad Sci U S A. 2018. PMID: 29382751.

57. Zaorsky NG, Lee CT, Zhang E, Galloway TJ. Skin Cancer Brachytherapy Vs External Beam Radiation Therapy (Scribe) Meta-Analysis. Radiother Oncol. 2018. PMID: 29370985.

58. Zeng Y, Hahn S, Stokes J, et al. Pak2 Regulates Myeloid-Derived Suppressor Cell Development in Mice. Blood Adv. 2017;1(22):1923-1933. PMID: 29296839. PMC5728145.

Staff Publications: December 2017

1. Ang C, Shields A, Xiu J, et al. Molecular Characteristics of Hepatocellular Carcinomas from Different Age Groups. Oncotarget. 2017;8(60):101591-101598. PMID: 29254188. PMC5731898.

2. Barbe MF, Krueger JJ, Loomis R, Otte J, Gordon J. Memory Deficits, Gait Ataxia and Neuronal Loss in the Hippocampus and Cerebellum in Mice That Are Heterozygous for Pur-Alpha. Neuroscience. 2016;337:177-190. PMID: 27651147. PMC5458736. NIHMS861948.

3. Bartel MJ, Srivastava A, Gordon S, Rothstein RI, Pohl H. Subsquamous Intestinal Metaplasia Is Common in Treatment-Naive Barrett’s Esophagus. Gastrointestinal Endoscopy. 2018;87(1):67-74.

4. Bartel MJ, Tokar JL. Non-Lifting Colorectal Neoplasia – Shall We Cast It Away? Endoscopy. 2018;50(1):6-7. PMID: 29268294.

5. Boushra M, Tous S, Fetih G, Xue HY, Tran NT, Wong HL. Methocel-Lipid Hybrid Nanocarrier for Efficient Oral Insulin Delivery. J Pharm Sci. 2016;105(5):1733-1740. PMID: 27012226.

6. Carnevale V, Klein ML. Small Molecule Modulation of Voltage Gated Sodium Channels. Curr Opin Struct Biol. 2017;43:156-162. PMID: 28363194. PMC5420475. NIHMS861097.

7. Coric P, Saribas AS, Abou-Gharbia M, et al. Nuclear Magnetic Resonance Structure of the Human Polyoma Jc Virus Agnoprotein. J Cell Biochem. 2017;118(10):3268-3280. PMID: 28295503. PMC5550335. NIHMS860648.

8. Correa AF, Handorf E, Joshi SS, et al. Differences in Survival by Receipt of Lymph Node Dissection in Patients with Invasive Penile Cancer: Results from the National Cancer Database. J Urol. 2017. PMID: 29248557.

9. Debenedetti PG, Klein ML. Chemical Physics of Water. Proc Natl Acad Sci U S A. 2017;114(51):13325-13326. PMID: 29229822.

10. Evans JD, Hansen CC, Tollefson MK, Hallemeier CL. Stereotactic Body Radiation Therapy for Medically Inoperable, Clinically Localized, Urothelial Carcinoma of the Renal Pelvis: A Case Report. Advances in Radiation Oncology. 2017.

11. Gerstenhaber JA, Barone FC, Marcinkiewicz C, et al. Vascular Thrombus Imaging in Vivo Via near-Infrared Fluorescent Nanodiamond Particles Bioengineered with the Disintegrin Bitistatin (Part Ii). Int J Nanomedicine. 2017;12:8471-8482. PMID: 29200855. PMC5703177.

12. Giri VN, Knudsen KE, Kelly WK, et al. Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017. J Clin Oncol. 2017:Jco2017741173. PMID: 29236593.

13. Gupta S, Provenzale D, Regenbogen SE, et al. Nccn Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 3.2017. J Natl Compr Canc Netw. 2017;15(12):1465-1475. PMID: 29223984.

14. Harshman LC, Chen YH, Liu G, et al. Seven-Month Prostate-Specific Antigen Is Prognostic in Metastatic Hormone Sensitive Prostate Cancer Treated with Androgen Deprivation with or without Docetaxel. J Clin Oncol. 2017:Jco2017753921. PMID: 29261442.

15. Hartmann BM, Albrecht RA, Zaslavsky E, et al. Pandemic H1n1 Influenza a Viruses Suppress Immunogenic Ripk3-Driven Dendritic Cell Death. Nat Commun. 2017;8(1):1931. PMID: 29203926. PMC5715119.

16. He S, Liu Y, Meng L, et al. Ezh2 Phosphorylation State Determines Its Capacity to Maintain Cd8(+) T Memory Precursors for Antitumor Immunity. Nat Commun. 2017;8(1):2125. PMID: 29242551. PMC5730609.

17. In TSH, Trotman-Grant A, Fahl S, et al. Heb Is Required for the Specification of Fetal Il-17-Producing Gammadelta T Cells. Nat Commun. 2017;8(1):2004. PMID: 29222418. PMC5722817.

18. Kingsberg SA, Althof S, Simon JA, et al. Female Sexual Dysfunction-Medical and Psychological Treatments, Committee 14. J Sex Med. 2017;14(12):1463-1491. PMID: 29198504.

19. Kline CLB, Ralff MD, Lulla AR, et al. Role of Dopamine Receptors in the Anticancer Activity of Onc201. Neoplasia. 2018;20(1):80-91. PMID: 29216597. PMC5725157.

20. Lazarovici P, Lahiani A, Gincberg G, et al. Nerve Growth Factor-Induced Angiogenesis: 1. Endothelial Cell Tube Formation Assay. Methods Mol Biol. 2018;1727:239-250. PMID: 29222786.

21. Lazarovici P, Lahiani A, Gincberg G, Haham D, Marcinkiewicz C, Lelkes PI. Nerve Growth Factor-Induced Angiogenesis: 2. The Quail Chorioallantoic Membrane Assay. Methods Mol Biol. 2018;1727:251-259. PMID: 29222787.

22. Levy RM, Haldane A, Flynn WF. Potts Hamiltonian Models of Protein Co-Variation, Free Energy Landscapes, and Evolutionary Fitness. Curr Opin Struct Biol. 2017;43:55-62. PMID: 27870991.

23. Li M, Sohn JA, Seeger C. Distribution of Hepatitis B Virus Nuclear DNA. J Virol. 2018;92(1). PMID: 29046450. PMC5730781.

24. Li P, Wong YN, Jahnke J, Pettit AR, Doshi JA. Association of High Cost Sharing and Targeted Therapy Initiation among Elderly Medicare Patients with Metastatic Renal Cell Carcinoma. Cancer Med. 2017. PMID: 29195016.

25. Lin T, Hossain M, Fan J, Ma CC. When and How to Treat an Imrt Patient on a Second Accelerator without Replanning? Med Dosim. 2017. PMID: 29287919.

26. Liu D, Abbosh P, Keliher D, et al. Mutational Patterns in Chemotherapy Resistant Muscle-Invasive Bladder Cancer. Nat Commun. 2017;8(1):2193. PMID: 29259186. PMC5736752.

27. Manne SL, Kashy D, Siegel SD, Heckman CJ. Group Therapy Processes and Treatment Outcomes in 2 Couple-Focused Group Interventions for Breast Cancer Patients. Psychooncology. 2017;26(12):2175-2185.

28. Manne SL, Myers-Virtue S, Kashy DA, et al. Therapy Processes, Progress, and Outcomes for 2 Therapies for Gynecological Cancer Patients. Psychooncology. 2017;26(12):2069-2078.

29. Mehrazin R, Dulaimi E, Uzzo RG, et al. The Correlation between Gain of Chromosome 8q and Survival in Patients with Clear and Papillary Renal Cell Carcinoma. Therapeutic Advances in Urology. 2018;10(1):3-10.

30. Meropol NJ, Feng Y, Grem JL, et al. Phase 2 Study of Treatment Selection Based on Tumor Thymidylate Synthase Expression in Previously Untreated Patients with Metastatic Colorectal Cancer: A Trial of the Ecog-Acrin Cancer Research Group (E4203). Cancer. 2017. PMID: 29211295.

31. Michael JV, Goldfinger LE. Concepts and Advances in Cancer Therapeutic Vulnerabilities in Ras Membrane Targeting. Semin Cancer Biol. 2017. PMID: 29203271.
32. Mortazavi SMJ. Comment on “Mobile Phone Radiofrequency Exposure Has No Effect on DNA Double Strand Breaks (Dsb) in Human Lymphocytes”. Ann Transl Med. 2017;5(21):441. PMID: 29201892. PMC5690963.

33. Mortazavi SMJ. Comments on “Wi-Fi Radiation Exposures to Children in Kindergartens and Schools – Results Should Lessen Parental Concerns”. Aust N Z J Public Health. 2017. PMID: 29235700.

34. Mortazavi SMJ. Letter to the Editor (July 26, 2017) Concerning the Paper “Impact of Electromagnetic Radiation Emitted by Monitors on Changes in the Cellular Membrane Structure and Protective Antioxidant Effect of Vitamin a – <I>in Vitro</I> Study”. Int J Occup Med Environ Health. 2018;31(3):371-372. PMID: 29209096.

35. Mortazavi SMJ, Mortazavi G. Re: Blood Mercury Concentration in Relation to Metabolic and Weight Phenotypes Using the Knhanes 2011-2013 Data. Int Arch Occup Environ Health. 2017. PMID: 29273973.

36. Nitzkorski JR, Willis AI, Nick D, Zhu F, Farma JM, Sigurdson ER. In Reply: Vitamin D Status May Explain Some of the Racial Disparities in Rectal Cancer. Ann Surg Oncol. 2017;24(Suppl 3):597. PMID: 29197042.

37. Norquist BM, Brady MF, Harrell MI, et al. Mutations in Homologous Recombination Genes and Outcomes in Ovarian Carcinoma Patients in Gog 218: An Nrg Oncology/Gynecologic Oncology Group Study. Clin Cancer Res. 2017. PMID: 29191972.

38. Peng H, Prokop J, Karar J, et al. Familial and Somatic Bap1 Mutations Inactivate Asxl1/2-Mediated Allosteric Regulation of Bap1 Deubiquitinase by Targeting Multiple Independent Domains. Cancer Res. 2017. PMID: 29284740.

39. Peng J, Meireles SI, Xu X, et al. Estrogen Metabolism in the Human Lung: Impact of Tumorigenesis, Smoke, Sex and Race/Ethnicity. Oncotarget. 2017;8(63):106778-106789.

40. Persky DO, Li H, Rimsza LM, et al. A Phase I/Ii Trial of Vorinostat (Saha) in Combination with Rituximab-Chop in Patients with Newly Diagnosed Advanced Stage Diffuse Large B-Cell Lymphoma (Dlbcl): Swog S0806. Am J Hematol. 2017. PMID: 29266344.

41. Ristau BT, Kutikov A. Editorial Comment. J Urol. 2017. PMID: 29227811.

42. Ristau BT, Manola J, Haas NB, et al. Retroperitoneal Lymphadenectomy for High Risk, Nonmetastatic Renal Cell Carcinoma: An Analysis of the Assure (Ecog-Acrin 2805) Adjuvant Trial. Journal of Urology. 2018;199(1):53-59.

43. Ristau BT, Smaldone MC. Editorial Comment. J Urol. 2017. PMID: 29287168.

44. Roboz GJ, Kantarjian HM, Yee KWL, et al. Dose, Schedule, Safety, and Efficacy of Guadecitabine in Relapsed or Refractory Acute Myeloid Leukemia. Cancer. 2017. PMID: 29211308.

45. Shah AY, Karam JA, Malouf GG, et al. Management and Outcomes of Patients with Renal Medullary Carcinoma: A Multicentre Collaborative Study. BJU Int. 2017;120(6):782-792. PMID: 27860149.

46. Shaikh T, Wang LS, Egleston B, et al. Predictors of Hematologic Toxicity and Chemotherapy Dose Intensity in Patients Undergoing Chemoradiation for Pancreatic Cancer. Am J Clin Oncol. 2018;41(1):59-64. PMID: 26325492. PMC4769977. NIHMS712811.

47. Shemesh A, Brusilovsky M, Kundu K, Ottolenghi A, Campbell KS, Porgador A. Splice Variants of Human Natural Cytotoxicity Receptors: Novel Innate Immune Checkpoints. Cancer Immunol Immunother. 2017. PMID: 29264698.

48. Smith EP, Li H, Friedberg JW, et al. Tandem Autologous Hematopoietic Cell Transplantation for Patients with Primary Progressive or Recurrent Hodgkin Lymphoma: A Swog and Blood & Marrow Transplant Clinical Trials Network Phase Ii Trial (Swog S0410/Bmt Ctn 0703). Biol Blood Marrow Transplant. 2017. PMID: 29289757.

49. Tamaki A, Miles BA, Lango M, Kowalski L, Zender CA. Ahns Series: Do You Know Your Guidelines? Review of Current Knowledge on Laryngeal Cancer. Head and Neck-Journal for the Sciences and Specialties of the Head and Neck. 2018;40(1):170-181.

50. Vijayvergia N, Cohen SJ. Cytotoxic Therapy in Advanced Pancreatic Cancer: Where We Are and Where We Are Headed. Current and Emerging Therapies in Pancreatic Cancer 2017:205-217.

51. von Mehren M, Joensuu H. Gastrointestinal Stromal Tumors. J Clin Oncol. 2017: PMID: 29220298.

52. Wang TP, Scott JH, Barta SK. The Evolving Role of Targeted Biological Agents in the Management of Indolent B-Cell Lymphomas. Ther Adv Hematol. 2017;8(12):329-344. PMID: 29204260. PMC5703116.

53. Warner EL, Ding Q, Pappas LM, Henry K, Kepka D. White, Affluent, Educated Parents Are Least Likely to Choose Hpv Vaccination for Their Children: A Cross-Sectional Study of the National Immunization Study – Teen. BMC Pediatr. 2017;17(1):200. PMID: 29191180. PMC5710112.

54. Winckworth-Prejsnar K, Nardi EA, McCanney J, et al. Ensuring Patient Safety and Access in Cancer Care. J Natl Compr Canc Netw. 2017;15(12):1460-1464. PMID: 29223983.

55. Xu MJ, Chu C, Rubin S, Lin LL. Survival Outcomes Improved in Contemporary Cohort of Patients with Pelvic or Abdominal Recurrence after Treatment for Stage I/Ii Endometrial Carcinoma. Am J Clin Oncol. 2017;40(6):598-604. PMID: 26237194. PMC4733581. NIHMS704405.

56. Xua QY, Fan JJ, Grimm J, et al. The Dosimetric Impact of the Prescription Isodose Line (Idl) on the Quality of Robotic Stereotactic Radiosurgery (Srs) Plans. Medical Physics. 2017;44(12):6159-6165.

57. Zhang YW, Nasto RE, Jablonski SA, et al. Rna Interference Screening to Identify Proliferation Determinants in Breast Cancer Cells. Bio Protoc. 2017;7(15). PMID: 29250574. PMC5730085. NIHMS898362.

58. Zuniga SA, Lango MN. Effect of Rural and Urban Geography on Larynx Cancer Incidence and Survival. Laryngoscope. 2017. PMID: 29238975.